Drug Database · Clinicians

Losartan

Brands (243) Besartan, Antoreb, Lifezar…Show all
Besartan · Antoreb · Lifezar · Starlo · Angisartan · Arbloc · Goztan 50 · Novasartan · Prestan · Saphlor-100 · Saphlor-50 · Angioten · Anzar · Azartan · Baczartan · Bepsar · Cozaar · Ekosart · Fisartan · Getzar · Hizar · Hypertan · Kardiostan · Kenzar · Lorcare · Lortavon · Losakind-50 · Losargard · Losartap · Losarx 100 · Losarx 50 · Lostan · Lostar-100 · Lotase · Lozak · Medzart · Myzar · Natrasol · Natrazol · Neosartan · Q-Pid · Raptrasol · Rapzar · Retasar · Sydentan · Technozar · Vivasartan · Vonsartan · Wilopres · Zarnat · Zartan-S · A.R.A · Amlopress · Andrezar · Andrezar-50 · Angel-100 · Angicee · Angiibloc · Angiolor · Angisartan-50 · Anin 50 · Antan · Arbcure · Arbisar-100 · Arbisar-50 · Artal · Arteva 100 · Arteva 50 · Articure 100 · Articure 50 · Artosar 50 · Artrice 100 · Artrice 50 · Bastisartan 100 · Bepsar-100 · Biozart 100 · Biozart 50 · BPbest · Cardiollen-100 · Cardiollen-50 · Cardizar · Congezar · Cordizar · Cotenace · Cozalyn · Cozalyn 100 · Curesartan · Curesartan 100 · Diassium 50 · Doxar · Dylaran-100 · Ebatan · Episartan · Fersartan · Fixtasart-100 · Flosartan · Gensartan · Gensartan 100 · Genzar · Gisart 50 · Gosartan-100 Extra · Gowin 100 · Grosartan · Hartzar · Hextan · Hyperthree · Jensar · Jiaazar · Jisartan · Jysartan 50 · Khrizaac · Kodisar · Kodisar 100 · Kozartan · Ksart 50 · L-Zerprime · Lanzaar 50 · Leesartan · Leesartan 100 · Lexzar · Lifetan · Lipewin · LO-K · Lodeesart · Lortan · Losa Speed 100 · Losaar 100 · Losaar 50 · Losabloc · Losacar · Losacar 100 · Losacraft-50 · Losacura · Losafil · Losagan-50 · Losagen 50 · Losaget · Losagold · Losamar-100 · LOSAMAR-50 · Losamax · Losan 50 · Losangio 50 · Losaprime · Losar-50 · Losaram · Losarbet · Losarcure · Losark · Losarkip 100 · Losarkip 50 · Losarlo · Losarniel · Losart · Losartfix · Losartrixx 100 · Losartrixx 50 · LosaSpeed 50 · Losastal-50 · Losaver · Losawin-100 · Losawin-50 · Losium · Losmac · Lossiutab · Lostar · Lostar-50 · Loxart · Loza 50 · Lozaar · Lozark 50 · Lozart 50 · Lozend 100 · Lozend 50 · Loztafixx · Mabisartan · Malsar · Melsartan · Moxifast · Myotan · Mysartan · Natrasol 100 · Navsartan · Neozart 50 · Newsartan · Nexart · Nipartan · Oranzar · Parten-50 · Pillsart · Potazar · Presartan-100 · Presartan-50 · Prolostan · Provizar · Prozart · Prozart 50 · Quezar 100 · Quezar 50 · Qxar · Regisart · Regizar-100 · Regizar-50 · Retasarc · Retazar · Retazart · Rigidon · Saranto 50 · Sartan · Sartan 100 · Sartangold · Sartanova-100 · Sartassium-100 · Sartassium-50 · Sartollen 100 · Sartollen 50 · Saztan · Shertan-100 · Shertan-50 · Spartan 50 · Tanzase · Tenzorich · Torlos-50 · VALLOSAR · Vamzar · Vascure 50 · Vasotas · VAZALIVE · Vazortan 50 · Venosartan · Welsartan · Wesartan · Ysartan · Zaran · Zarphil · Zarpose · Zartapel · Zebesar · Zelosart-100 · Zelosart-50 · Zilzart · Zilzart-S · Zyltan 50

Angiotensin II receptor blocker (ARB); Angiotensin II receptor antagonist; and others PH FDA category

Rx · Prescription drug375 PH productsPNF-listedPhilHealth GAMOTVAT-exempt (some products) Kidney dosing reviewed
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID 9949448f-c3b9-44ee-94ed-c1aca8c90f39, version date January 20, 2026 (COZAAR · Organon LLC). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • Treatment of hypertension, to lower blood pressure in adults and children greater than 6 years old.
  • Reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy.
  • Treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria in patients with type 2 diabetes and a history of hypertension.
US FDA label
Full indications and usage US FDA label

1 INDICATIONS AND USAGE COZAAR is an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure in adults and children greater than 6 years old. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.

(1.1) Reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy. There is evidence that this benefit does not apply to Black patients. (1.2) Treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria in patients with type 2 diabetes and a history of hypertension.

(1.3) 1.1 Hypertension COZAAR ® is indicated for the treatment of hypertension in adults and pediatric patients 6 years of age and older, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and nonfatal cardiovascular (CV) events, primarily strokes and myocardial infarction. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including losartan.

Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program's Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).

Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.

Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.

Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in Black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy. COZAAR may be administered with other antihypertensive agents. 1.2 Hypertensive Patients with Left Ventricular Hypertrophy COZAAR is indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy, but there is evidence that this benefit does not apply to Black patients [see Use in Specific Populations (8.6) and Clinical Pharmacology (12.3)]. 1.3 Nephropathy in Type 2 Diabetic Patients COZAAR is indicated for the treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria (urinary albumin to creatinine ratio ≥300 mg/g) in patients with type 2 diabetes and a history of hypertension.

In this population, COZAAR reduces the rate of progression of nephropathy as measured by the occurrence of doubling of serum creatinine or end stage renal disease (need for dialysis or renal transplantation) [see Clinical Studies (14.3)].

Contraindications

  • Hypersensitivity to any component
  • Coadministration with aliskiren in patients with diabetes
renalcarematters.com, reviewed
Contraindications (US label) US FDA label

4 CONTRAINDICATIONS COZAAR is contraindicated: In patients who are hypersensitive to any component of this product. For coadministration with aliskiren in patients with diabetes. Hypersensitivity to any component. (4) Coadministration with aliskiren in patients with diabetes. (4)

Dosing: Adult

  • Hypertension (adults): 50 mg once daily; up to 100 mg once daily; 25 mg start if possible volume depletion (e.g., on diuretics)
  • Hypertension with left ventricular hypertrophy: 50 mg once daily; add HCTZ 12.5 mg and/or increase to 100 mg, then HCTZ 25 mg as needed
  • Diabetic nephropathy (type 2 diabetes): 50 mg once daily; increase to 100 mg once daily for blood pressure
renalcarematters.com, reviewed
Dosage and administration (US label) US FDA label
  • Hypertension Usual adult dose: 50 mg once daily. (2.1)
  • Usual pediatric starting dose: 0.7 mg per kg once daily (up to 50 mg). (2.1)
  • Hypertensive Patients with Left Ventricular Hypertrophy Usual starting dose: 50 mg once daily. (2.2)
  • Add hydrochlorothiazide 12.5 mg and/or increase COZAAR to 100 mg followed by an increase to hydrochlorothiazide 25 mg if further blood pressure response is needed. (2.2, 14.2)
  • Nephropathy in Type 2 Diabetic Patients Usual dose: 50 mg once daily. (2.3)
  • Increase dose to 100 mg once daily if further blood pressure response is needed. (2.3)
2.1 Hypertension Adult

2.1 Hypertension Adult Hypertension The usual starting dose of COZAAR is 50 mg once daily. The dosage can be increased to a maximum dose of 100 mg once daily as needed to control blood pressure [see Clinical Studies (14.1)]. A starting dose of 25 mg is recommended for patients with possible intravascular depletion (e.g., on diuretic therapy).

Pediatric Hypertension The usual recommended starting dose is 0.7 mg per kg once daily (up to 50 mg total) administered as a tablet or a suspension [see Dosage and Administration (2.5)]. Dosage should be adjusted according to blood pressure response. Doses above 1.4 mg per kg (or in excess of 100 mg) daily have not been studied in pediatric patients [see Clinical Pharmacology (12.3), Clinical Studies (14.1), and Warnings and Precautions (5.2)].

COZAAR is not recommended in pediatric patients less than 6 years of age or in pediatric patients with estimated glomerular filtration rate less than 30 mL/min/1.73 m² [see Use in Specific Populations (8.4), Clinical Pharmacology (12.3), and Clinical Studies (14)].

2.2 Hypertensive Patients with Left Ventricular

2.2 Hypertensive Patients with Left Ventricular Hypertrophy The usual starting dose is 50 mg of COZAAR once daily. Hydrochlorothiazide 12.5 mg daily should be added and/or the dose of COZAAR should be increased to 100 mg once daily followed by an increase in hydrochlorothiazide to 25 mg once daily based on blood pressure response [see Clinical Studies (14.2)].

2.3 Nephropathy in Type 2 Diabetic Patients

2.3 Nephropathy in Type 2 Diabetic Patients The usual starting dose is 50 mg once daily. The dose should be increased to 100 mg once daily based on blood pressure response [see Clinical Studies (14.3)].

2.4 Dosage Modifications in Patients with Hepatic Impairment

2.4 Dosage Modifications in Patients with Hepatic Impairment In patients with mild-to-moderate hepatic impairment the recommended starting dose of COZAAR is 25 mg once daily. COZAAR has not been studied in patients with severe hepatic impairment [see Use in Specific Populations (8.8) and Clinical Pharmacology (12.3)].

2.5 Preparation of Suspension (for 200 mL of a 2.5 mg/mL suspension)

2.5 Preparation of Suspension (for 200 mL of a 2.5 mg/mL suspension) Add 10 mL of Purified Water USP to an 8 ounce (240 mL) amber polyethylene terephthalate (PET) bottle containing ten 50 mg COZAAR tablets. Immediately shake for at least 2 minutes. Let the concentrate stand for 1 hour and then shake for 1 minute to disperse the tablet contents.

Separately prepare a 50/50 volumetric mixture of Ora-Plus ™ and Ora-Sweet SF ™. Add 190 mL of the 50/50 Ora-Plus ™ /Ora-Sweet SF ™ mixture to the tablet and water slurry in the PET bottle and shake for 1 minute to disperse the ingredients. The suspension should be refrigerated at 2-8°C (36-46°F) and can be stored for up to 4 weeks.

Shake the suspension prior to each use and return promptly to the refrigerator.

Dosing: Altered kidney function

Losartan, an angiotensin II receptor blocker (ARB), needs no dose change for kidney impairment alone per the US label, unless the patient is also volume depleted. Neither losartan nor its active metabolite is removed by hemodialysis.

Kidney function measure: Label PK uses creatinine clearance (CrCl); dosing statement is not band-specific.

Show full dosing details
eGFR ≥60
Usual dosing: 50 mg once daily, up to 100 mg once daily.
eGFR 30–59
No adjustment unless volume depleted (label). Exposure is 50 to 90% higher in mild to moderate impairment.
eGFR 15–29
No adjustment unless volume depleted (label). Monitor potassium and creatinine.
eGFR <15 (not on dialysis)
No label adjustment; monitor potassium, creatinine and blood pressure closely.
Hemodialysis (intermittent)
No adjustment in the label; not removed by hemodialysis.
Peritoneal dialysis
No label adjustment; no PD data.
CRRT
No data in label.
  • Dialyzable? No: neither losartan nor its active metabolite is removed by hemodialysis (label).
  • Monitoring Serum creatinine and potassium 2 to 4 weeks after starting or changing the dose; a creatinine rise up to 30% is expected and is not a reason to stop. Correct volume depletion before starting (label). KDIGO 2024 supports continuing the ARB when eGFR falls below 30.
Children (kidney dosing)
Show full dosing details
eGFR ≥60
Usual pediatric dose.
eGFR 30–59
Usual pediatric dose (no label adjustment); monitor potassium and creatinine.
eGFR 15–29
Not recommended: GFR <30 mL/min/1.73 m2 (label).
eGFR <15 (not on dialysis)
Not recommended (label).
Hemodialysis (intermittent)
Not recommended (GFR <30).
Peritoneal dialysis
Not recommended (GFR <30).
CRRT
Not recommended.

Pediatric eGFR: bedside Schwartz equation, 0.413 × height (cm) / serum creatinine (mg/dL). Weight-based doses should not exceed the adult maximum.

renalcarematters.com guidance, reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 16, 2026. Sources are listed under References. Use with the product's package insert and the patient's current kidney function.

US label text: Renal impairment US FDA label

8.7 Renal Impairment Patients with renal insufficiency have elevated plasma concentrations of losartan and its active metabolite compared to subjects with normal renal function. No dose adjustment is necessary in patients with renal impairment unless a patient with renal impairment is also volume depleted [see Dosage and Administration (2.3), Warnings and Precautions (5.3) and Clinical Pharmacology (12.3)].

Renal Insufficiency: Following oral administration, plasma concentrations and AUCs of losartan and its active metabolite are increased by 50-90% in patients with mild (creatinine clearance of 50 to 74 mL/min) or moderate (creatinine clearance 30 to 49 mL/min) renal insufficiency. In this study, renal clearance was reduced by 55-85% for both losartan and its active metabolite in patients with mild or moderate renal insufficiency. Neither losartan nor its active metabolite can be removed by hemodialysis [see Warnings and Precautions (5.3) and Use in Specific Populations (8.7)].

Dosing: Hepatic impairment

8.8 Hepatic Impairment The recommended starting dose of COZAAR is 25 mg in patients with mild-to-moderate hepatic impairment. Following oral administration in patients with mild-to-moderate hepatic impairment, plasma concentrations of losartan and its active metabolite were, respectively, 5 times and 1.7 times those seen in healthy volunteers. COZAAR has not been studied in patients with severe hepatic impairment [see Dosage and Administration (2.4) and Clinical Pharmacology (12.3)].

2.4 Dosage Modifications in Patients with Hepatic Impairment In patients with mild-to-moderate hepatic impairment the recommended starting dose of COZAAR is 25 mg once daily. COZAAR has not been studied in patients with severe hepatic impairment [see Use in Specific Populations (8.8) and Clinical Pharmacology (12.3)].

US FDA label

Dosing: Pediatric

Approved ages
Hypertension, 6 to 16 years (label). Not established under 6 years or with GFR <30 mL/min/1.73 m2.
Usual dose
0.7 mg/kg once daily (up to 50 mg); doses above 1.4 mg/kg (or above 100 mg) daily have not been studied (label).
Maximum dose
1.4 mg/kg/day, not to exceed 100 mg/day (studied range per label).
Neonates
Neonates: not recommended (under 6 years). In utero exposure: support blood pressure and renal perfusion if oliguria or hypotension.

Kidney dosing in children: see Dosing: Altered kidney function.

renalcarematters.com, reviewed
Pediatric use (US label) US FDA label

8.4 Pediatric Use Antihypertensive effects of COZAAR have been established in hypertensive pediatric patients aged 6 to 16 years. Safety and effectiveness have not been established in pediatric patients under the age of 6 or in pediatric patients with glomerular filtration rate <30 mL/min/1.73 m² [see Dosage and Administration (2.1), Clinical Pharmacology (12.3), and Clinical Studies (14.1)].

Dosing: Older adult

Geriatric use (US label) US FDA label

8.5 Geriatric Use Of the total number of patients receiving COZAAR in controlled clinical studies for hypertension, 391 patients (19%) were 65 years and over, while 37 patients (2%) were 75 years and over. In a controlled clinical study for renal protection in type 2 diabetic patients with proteinuria, 248 patients (33%) were 65 years and over.

In a controlled clinical study for the reduction in the combined risk of cardiovascular death, stroke and myocardial infarction in hypertensive patients with left ventricular hypertrophy, 2857 patients (62%) were 65 years and over, while 808 patients (18%) were 75 years and over. No overall differences in effectiveness or safety were observed between these patients and younger patients, but greater sensitivity of some older individuals cannot be ruled out.

Administration

2.5 Preparation of Suspension (for 200 mL of a 2.5 mg/mL suspension) Add 10 mL of Purified Water USP to an 8 ounce (240 mL) amber polyethylene terephthalate (PET) bottle containing ten 50 mg COZAAR tablets. Immediately shake for at least 2 minutes. Let the concentrate stand for 1 hour and then shake for 1 minute to disperse the tablet contents. Separately prepare a 50/50 volumetric mixture of Ora-Plus ™ and Ora-Sweet SF ™ . Add 190 mL of the 50/50 Ora-Plus ™ /Ora-Sweet SF ™ mixture to the tablet and water slurry in the PET bottle and shake for 1 minute to disperse the ingredients. The suspension should be refrigerated at 2-8°C (36-46°F) and can be stored for up to 4 weeks. Shake the suspension prior to each use and return promptly to the refrigerator.

US FDA label

Dosage forms

Philippines

  • Film-coated tablet: 50 mg, 100 mg, 500 mg
  • Tablet: 50 mg, 100 mg

Registered products in the Philippines

375 products registered with the Food and Drug Administration (FDA) Philippines list Losartan as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Also registered under: Losartan Potassiumn (1 product). Products registered under these spellings are included in the table and marked.

Verify on PH FDA portal

All registered products375
Philippine FDA-registered products for Losartan
Package insert
A.R.ALosartan Potassium
50 mg Film-Coated TabletAlu-Alu Blister Pack x 10's packed in individual boxes (Box of 100’s)
RxVAT-exempt
Zim Laboratories LimitedIndia
Suhitas Pharmaceuticals Inc.Trader: PSA International (Export Division of PSA Chemicals & Pharmaceuticals Pvt. Ltd.)
DRP-906
Apr 22, 2028
AmlopressLosartan potassium
50 mg Film-Coated TabletAlu/ PVC/ PVDC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
Maraki Pharma Co.Importer: Amb Hk Enterprises Inc.
DRP-8522-08
Oct 25, 2029
AndrezarLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Zim Laboratories LimitedIndia
Carl Andre Trading CorporationImporter: Medinova Pharmaceutical Inc.
DRP-8985-12
Jul 21, 2030
Andrezar-50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Zim Laboratories LimitedIndia
Carl Andre Trading CorporationImporter: Medinova Pharmaceutical Inc.
DRP-8985-14
Jul 21, 2030
Angel-100Losartan potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Healer's Lab (Unit II)India
Pharmakon Biotec Inc.
DRP-12727
Sep 28, 2027
AngiceeLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's & 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
CDMed Pharmaceutical and Medical SupplyImporter: Pharmakon Biotec Inc.
DRP-13687-15
Mar 28, 2028
AngiiblocLosartan Potassium
50 mg Film-Coated TabletAlu-Opaque White PVC Blister Pack x 10's (Box of 30's, 50's, and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Day to Day Pharmacy
DRP-12412-14
Sep 19, 2031
AngiolorLosartan Potassium
100 mg Film-Coated TabletAlu/Clear PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Medirich Pharma Distribution Corp.Trader: Eadriex Pharmaceuticals, Phils., Inc.
DRP-2635
Nov 26, 2029
AngiotenLosartan (as Potassium)
100 mg TabletAlu/Red PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Drugmaker's Laboratories, Inc.Philippines
—
DRP-7208
Sep 4, 2030
AngiotenLosartan Potassium
50 mg TabletAlu/Red PVC Blister pack x 20's (Box of 100's); Alu/Red PVC Blister pack x 10's (Box of 30's )(For DOH USE only)
RxVAT-exempt
Drugmaker's Laboratories Inc.Philippines
—
DRP-7209
Sep 2, 2030
AngisartanLosartan potassium
50 mg Film-coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Novagen Healthcare Private LimitedIndia
I.E. Medica, Inc.Trader: Plethico Laboratories Pvt. Ltd.
DRP-14267
Jun 30, 2028
AngisartanLosartan Potassium
50 mg Film-Coated tabletBlister Pack x 10's (Box of 100's); Blister Pack x 14's (Box of 140's); Blister Pack x 10's (Box of 30's) [For DOH Use Only]
RxVAT-exempt
Plethico Pharmaceuticals Ltd.India
I.E. Medica, Inc.Trader: Wiscon Pharmaceuticals Pvt. Ltd.
DRP-996
Nov 12, 2027
AngisartanLosartan Potassium
50mg Film-Coated TabletsAlu/PVC Blister pack x 10's (Box of 100' s)
RxVAT-exempt
Novagen Healthcare Private LimitedIndia
I.E. Medica, Inc.Trader: Plethico Laboratories Pvt. Ltd.
DR-XY48796
Jun 30, 2028
Angisartan-50Losartan Potassium
50 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Novagen Healthcare Private Limitedindia
I.E. Medica, Inc.
DRP-17573
Feb 2, 2028
Anin 50Losartan Potassium
50 mg Film-Coated TabletAlu-PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Delta Pharma Ltd.Bangladesh
Biomed Pharma Inc.
DR-XY39746
Jul 11, 2031
AntanLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's).
RxVAT-exempt
PSA Chemicals & Pharmaceuticals Pvt. Ltd.India
Orange Biotec Inc.
DRP-15448
Jul 10, 2029
AntorebLosartan Potassium
100 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Sapphire Lifesciences Pvt. Ltd.India
ECE Pharmaceuticals, Inc.Importer: Nelpa Lifesciences Inc.
DRP-12531-01
Sep 2, 2027
AntorebLosartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 60's, 90's and 100's)
RxVAT-exempt
Innovative HealthcareIndia
ECE Pharmaceuticals, Inc.Importer: Biophil Medical Equipment and Supplies Trading
DRP-18346
Jun 18, 2031
AntorebLosartan Potassium
50 mg Film-coated TabletAlu/Alu Blister Pack of 10's (Box of 100's)
RxVAT-exempt
Sapphire Lifesciences Pvt. Ltd.India
ECE Pharmaceutical,Inc.Importer: Nelpa Lifesciences Inc.
DRP-12532-01
Sep 2, 2027
AntorebLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Innovative HealthcareIndia
ECE Pharmaceuticals, Inc.Importer: Biophil Medical Equipment and Supplies Trading
DRP-18347
Jun 18, 2031
AnzarLosartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister pack x 10's (Box of 30's)
RxVAT-exempt
MEDISURE LABORATORIES PAKISTAN (PVT) LTDPakistan
ADP PHARMA CORPORATIONImporter: STANGEN PHARMACEUTICALS PHILIPPINES INC
DRP-4775
Oct 3, 2029
AnzarLosartan Potassium
50 mg TabletAlu/Alu Blister Pack x 10's Box of 30's and 100's
RxVAT-exempt
MICRO LABS LIMITEDIndia
ADP PHARMA CORPORATIONImporter: BROWN & BURK PHILS., INC.
DRP-897-01
Oct 22, 2029
ArbcureLosartan Potassium
50 mg Film-Coated TabletAlu / Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Pharmacure Medical Supplies TradingImporter: Pharmakon Biotec Inc.
DRP-13687-22
Mar 28, 2028
Arbisar-100Losartan Potassium
100 mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc.
DRP-8523-01
Oct 25, 2029
Arbisar-50Losartan Potassium
50 mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc.
DRP-8522-01
Oct 25, 2029
ArblocLosartan Potassium
100 mg Film-Coated TabletAlu/White PVDC Blister Pack x 10’s (Box of 30’s, 50’s and 100’s)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
The Cathay YSS Distributors Co., Inc.
DRP-1667-07
Mar 12, 2037
ArblocLosartan Potassium
50 mg Film-Coated TabletFoil Strip x 10's (Box of 30's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Trader: The Cathay YSS Distributors Company, Inc.
DR-XY34525
Feb 1, 2027
ArblocLosartan Potassium
50 mg Film-Coated TabletWhite PVDC Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
The Cathay YSS Distributors Co., Inc.
DRP-128-10
Oct 10, 2030
ArtalLosartan Potassium
50 mg Film-Coated TabletAlu/Alu blister pack x 10’s (Box of 100's)
RxVAT-exempt
Hiral Labs LimitedIndia
Qualifirst Health Inc.Importer: Aglobal Care, Inc.
DRP-8058
Apr 29, 2031
Arteva 100Losartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-13686-04
Mar 28, 2028
Arteva 50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-13687-05
Mar 28, 2028
Articure 100Losartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-13686-02
Mar 28, 2028
Articure 50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-13687-02
Mar 28, 2028
Artosar 50Losartan potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's and 100's)
RxVAT-exempt
Zest PharmaIndia
Sahar International Trading, Inc.Trader: NGB Laboratories Pvt. Ltd.
DR-XY43661
Nov 19, 2030
Artrice 100Losartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-13686-03
Mar 28, 2028
Artrice 50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-13687-03
Mar 28, 2028
AzartanLosartan Potassium
100 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 10's (Box of 30's, 50's, 100;s)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
—
DRP-15663
Aug 16, 2029
AzartanLosartan Potassium
50 mg Film-Coated TabletAlu-Opaque White PVC Blister Pack x 10's (Box of 30's, 50's, and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories, Inc.Philippines
—
DRP-12412
Aug 3, 2031
BaczartanLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mankind Pharma Limited (Unit II)India
JJYSRINN Trading Inc.Importer: Ambica International Corporation
DRP-12057-01
Jun 3, 2027
BaczartanLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 60's and 100's)
RxVAT-exempt
Windlas Biotech Limited (Plant-1)India
JJYSRINN Trading Inc.Importer: Ambica International CorporationTrader: Mankind Pharma Ltd.
DRP-5960-01
Feb 4, 2028
Bastisartan 100Losartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30's and 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India 174101
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-13686-13
Mar 28, 2028
BepsarLosartan Potassium
50 mg Film-Coated TabletAlu/Clear PVC Blister Pack X 10's (Box of 30's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
EuroAsia Pharmaceuticals, IncTrader: Tunic Healthcare
DR-XY44643
Jun 17, 2030
BepsarLosartan Potassium
50 mg TabletFoil Strip x 10’s (Box of 30’s)
RxVAT-exempt
Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals and Pharmaceuticals Limited)India
Euroasia Pharmaceuticals, Inc.Importer: Ambica International Corporation
DRP-841-05
May 4, 2027
Bepsar-100Losartan Potassium
100 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
EuroAsia Pharmaceuticals, Inc.Trader: Tunic Healthcare
DRP-14504
Sep 15, 2028
BesartanLosartan Potassium
50 mg Film-Coated TabletAlu/White PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Berlin Pharmaceutical Industry Co., Ltd.Thailand
Littman Drug CorporationImporter: Paradigm Pharma (Philippines) CorporationTrader: Paradigm Pharma (Thailand) Co., Ltd.
DRP-13778-01
Feb 18, 2029
BesartanLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 100's
RxVAT-exempt
Torrent Pharmaceuticals Ltd.India
Littman Drug CorporationImporter: Torrent Pharma Philippines, Inc.
DRP-2845-01
Jul 24, 2027
BesartanLosartan Potassium
50 mg Film-Coated TabletWhite Opaque PVC/Alu/Alu Blister Pack x 14's (Box of 28's); White Opaque PVC/Alu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Ipca Laboratories LimitedIndia
Littman Drug CorporationImporter: Blue Global (FZE)
DRP-3971-03
Mar 15, 2030
BesartanLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Littman Drug CorporationTrader: Totalcare Pharma Inc.
DRP-982-03
May 28, 2027
BesartanLosartan Potassium
50 mg TabletFoil Strip x 10’s (Box of 100’s)
RxVAT-exempt
Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals and Pharmaceuticals Limited)India
Diafarm Inc.Importer: Ambica International Corporation
DRP-841-03
May 4, 2027
Biozart 100Losartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Pharmakon Biotec Inc.
DRP-13686
Mar 28, 2028
Biozart 50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Pharmakon Biotec Inc.
DRP-13687
Mar 28, 2028
BPbestLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Synmedic LaboratoriesIndia
TGIF Pharmaceutical Trading Inc.Importer: Ambica International Corporation
DRP-2591-07
Jul 31, 2028
Cardiollen-100Losartan Potassium
100 mg Film-Coated TabletAlu/PVC Blister Pack x 10’s (Box of 30’s); Alu/PVC Blister Pack x 10’s Box of 60’s; Alu/PVC Blister Pack x 10’s Box of 90’s; Alu/PVC Blister Pack x 10’s Box of 100’s
RxVAT-exempt
Sai Parenterals Ltd.India
Ollen Pharma Trading Inc.Importer: Nelpa Lifesciences, Inc.
DRP-10666-01
Apr 2, 2030
Cardiollen-50Losartan Potassium
50 mg Film-Coated TabletAlu / PVC Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Sai Parenterals Ltd.India
Ollen Pharma Trading Inc.Importer: Nelpa Lifesciences, Inc.
DRP-10667-02
Jan 30, 2030
CardizarLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 30's
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Solvang Pharmaceuticals, Inc.Trader: Totalcare Pharma Inc.
DRP-982-02
May 28, 2027
CongezarLosartan Potassium
50 mg Film-Coated Tablet. Alu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Synmedic Laboratories.India
AGB Pharmaceutical Trading and ConsultancyImporter: Ambica International Corporation
DRP-2591-04
Jul 31, 2028
CordizarLosartan Potassium
50 mg Film-Coated TablerAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
J.M. Tolmann Laboratories, Inc.Philippines
D and JB Pharma Medica Corp.Trader: Interhealthcare Pharmaceuticals Inc.
DRP-1216-01
Jul 30, 2028
CotenaceLosartan Potassium
50 mg Film-Coated TabletBlister Pack x 10's Box of 100's
RxVAT-exempt
Flamingo Pharmaceuticals Ltd.India
Hexagon Pharmaceuticals
DRP-722
Oct 8, 2027
CozaarLosartan potassium
100mg TabletOpaque PVC/PE/PVDC blister pack x l0's (Box of 30's)
RxVAT-exempt
Organon Pharma (UK) LimitedUnited Kingdom
Importer: Organon (Philippines) Incorporated
DRP-6250
Dec 10, 2027
COZAARLosartan Potassium
50 mg TabletOpaque, White Alu/PE/PVC/PVDC Blister Pack x 10's Box of 30's
RxVAT-exempt
Organon Pharma (UK) LimitedUnited Kingdom
Importer: Organon (Philippines) Incorporated
DRP-6249
Mar 24, 2029
CozalynLosartan Potassium
50 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mankind Pharma Limited (Unit II)India
Vitalife Pharma & Medical Supply Inc.Importer: I.E. Medica, Inc.
DRP-8657-03
Jan 31, 2030
Cozalyn 100Losartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Dagon Pharmaceuticals Pvt. Ltd.India
Vitalife Pharma & Medical Supply Inc.Importer: Philgen Pharmaceuticals Inc.
DRP-15133-01
May 8, 2029
CuresartanLosartan potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Diafarm Inc.Importer: Ambica International Corporation
DRP-6453-03
Nov 27, 2030
Curesartan 100Losartan Potassium
100 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Diafarm Inc.Importer: Ambica International Corporation
DRP-4693-12
Sep 6, 2028
Diassium 50Losartan (as Potassium)
50 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
XL Laboratories Pvt. Ltd.India
Diafarm Inc.Importer: Ambica International Corporation
DRP-3183-04
Jun 7, 2032
DoxarLosartan Potassium
50 mg Film-Coated TabletAlu/PVC Blister Pack x 10’s Box of 100’s
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Trader: PNSV ASIA CORPORATION
DR-XY35051
Oct 16, 2028
Dylaran-100Losartan Potassium
100 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Better Option Pharmaceuticals, Inc.Importer: Ambica International Corporation
DRP-4693-01
Sep 6, 2028
EbatanLosartan Potassium
50 mg Film-Coated TabletAlu-Opaque White PVC Blister Pack x 10's (Box of 30's, 50's, and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Eba Generisch Trading Inc.
DRP-12412-04
Sep 19, 2031
EkosartLosartan Potassium
100 mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 15's (Box of 30's)
RxVAT-exempt
Sandoz Grup Saglik Urunleri Ilaclari Sanayi Ve Ticaret A.S.Turkey
TGP Pharma Inc.Importer: Sandoz Philippines Corporation
DRP-2184-01
Jul 7, 2029
EkosartLosartan Potassium
50 mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 15's (Box of 30's)
RxVAT-exempt
Sandoz Grup Saglik Urunleri Ilaclari Sanayi Ve Tiracet A.S. (Gebze 2)Turkey
TGP Pharma Inc.Importer: Sandoz Philippines Corporation
DRP-2183-01
Jan 26, 2030
EpisartanLosartan Potassium
50 mg TabletAlu/PVC Blister Pack x 10’s (Box of 30’s; Box of 60's and Box of 100's)
RxVAT-exempt
Kopran LimitedIndia
Epione Lifecare Inc.Importer: Despina Pharma Inc.
DRP-13056-02
Nov 23, 2027
FersartanLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Ferma Drug EnterprisesImporter: Pharmakon Biotec Inc.
DRP-13687-19
Mar 28, 2028
FisartanLosartan Potassium
100 mg Film-Coated TabletPVC Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
J.M. Tolmann Laboratories Inc.Philippines
Firstmed Theraconcept Inc.Trader: Interhealthcare Pharmaceuticals Inc.
DRP-1100-08
Dec 17, 2030
FISARTANLosartan Potassium
50 mg Film-Coated TabletAlu/PVC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
J.M. TOLMANN LABORATORIES INC.Philippines
FIRSTMED THERACONCEPT INC.Trader: INTERHEALTHCARE PHARMACEUTICAL INC.
DRP-1216-08
Jul 30, 2028
Fixtasart-100Losartan Potassium
100 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Emil Pharmaceutical Industries Private LimitedIndia
Ambitech Biopharmaceuticals Inc.Importer: Ambica International CorporationTrader: Chempro Pharma Pvt. Ltd.
DRP-10067-07
May 26, 2028
FlosartanLosartan Potassium
50 mg Film-Coated TabletAluminum Strip Foil x 10's (Box of 30's); Aluminum Strip Foil x 10's (Box of 100's)
RxVAT-exempt
Bauch Phils. Laboratories Corp.Philippines
Lo-Ar Pharmaceutical Co., Inc.
DRP-4884
Oct 31, 2028
GensartanLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister pack x 10's (Box of 100's)
RxVAT-exempt
Zim Laboratories LimitedIndia
Skymed Pharma DistributorImporter: Medinova Pharmaceutical Inc.
DRP-8985-02
Aug 6, 2031
Gensartan 100Losartan potassium
100 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Ratnatris Pharmaceuticals Private LimitedIndia
Skymed Pharma DistributorImporter: Medinova Pharmaceutical Inc.
DRP-16506-03
Apr 2, 2030
GenzarLosartan Potassium
50 mg Film-Coated TabletAlu-Opaque White PVC Blister Pack x 10's (Box of 30's, 50's, and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Eba Generisch Trading Inc.
DRP-12412-03
Jul 14, 2031
GetzarLosartan Potassium
100 mg Film-Coated TabletAlu/White PVDC Blister Pack x 10’s (Box of 50’s)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Getz Pharma (Phils.), Inc.
DRP-1667-02
Aug 11, 2030
GetzarLosartan Potassium
50 mg Film-Coated TabletWhite PVDC Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Getz Pharma (Phils.), Inc.
DRP-128-04
Oct 10, 2030
Gisart 50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Zim Laboratories LimitedIndia
Gijun Trading Inc.Importer: Medinova Pharmaceutical Inc.
DRP-8985-03
Aug 6, 2031
Gosartan-100 ExtraLosartan Potassium
100 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Applied Pharmaceutical Distribution Inc.Importer: Ambica International Corporation
DRP-4693-09
Sep 6, 2028
Gowin 100Losartan Potassium
100 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-4693-03
Sep 6, 2028
Goztan 50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Synmedic LaboratoriesIndia
Applied Pharmaceutical Distribution Inc.Importer: Ambica International Corporation
DRP-2591-09
Jul 31, 2028
Goztan 50Losartan Potassium
50 mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 10's (Box of 30’s and 100’s)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
Applied Pharmaceutical Distribution Inc.Importer: AMB HK Enterprises Inc.
DRP-8522-09
Oct 25, 2029
Goztan-50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Zim Laboratories LimitedIndia
Applied Pharmaceutical Distribution Inc.Importer: Medinova Pharmaceutical Inc.
DRP-8985-07
Jul 21, 2030
GrosartanLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 50's and 100's)
RxVAT-exempt
J. Duncan Healthcare Pvt. Ltd.India
Grovic Pharma, Inc.
DRP-7302
Apr 5, 2031
HartzarLosartan Potassium
50 mg Film-Coated TabletWhite PVDC Blister Pack x 10's (Box of 50's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Pharma Dynamic, Inc.
DRP-128-05
Oct 10, 2030
HextanLosartan Potassium
50 mg Film-Coated TabletBlister Pack x 10's (Box of 100's)
RxVAT-exempt
Flamingo Pharmaceuticals Ltd.India
Trumed PharmaceuticalsImporter: Hexagon Pharmaceuticals
DRP-722-03
Oct 8, 2027
HizarLosartan Potassium
100 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
Harlem SalesImporter: Philgen Pharmaceuticals, Inc.
DRP-1882-04
Mar 4, 2027
HizarLosartan Potassium
50 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
Harlem SalesImporter: Philgen Pharmaceuticals Inc.
DRP-1884-04
Sep 14, 2027
HypertanLosartan Potassium
100 mg Film-Coated TabletPVC Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
J.M. Tolmann Laboratories, Inc.Philippines
TGP Pharma Inc.Trader: Interhealthcare Pharmceuticals Inc.
DRP-1100
Dec 17, 2029
HypertanLosartan Potassium
50 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
J.M. Tolmann Laboratories, Inc.Philippines
TGP Pharma Inc.Trader: Interhealthcare Pharmaceuticals Inc.
DRP-1216
Jul 30, 2028
HyperthreeLosartan Potassium
50 mg Film-Coated TabletWhite PVDC Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
One Pharma Marketing Inc.
DRP-128-02
Oct 10, 2030
JensarLosartan Potassium
50 mg TabletFoil Strip x 10’s (Box of 100’s)
RxVAT-exempt
Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals and Pharmaceuticals LimitedIndia
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-841-01
May 4, 2027
JiaazarLosartan Potassium
50 mg Film-Coated TabletAlu / PVC / PVDC Blister Pack x 10’s (Box of 30’s & Box of 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
Jiaa PharmaImporter: AMB HK Enterprises Inc.
DRP-8522-06
Oct 25, 2029
JisartanLosartan Potassium
50 mg Film-Coated TabletAlu-Alu Blister Pack x 10's packed in individual boxes (Box of 100's)
RxVAT-exempt
Zim Laboratories LimitedIndia
Jiaa PharmaImporter: Suhitas Pharmaceuticals Inc.Trader: PSA International (Export Division of PSA Chemicals & Pharmaceuticals Pvt. Ltd.)
DRP-906-07
Apr 22, 2028
Jysartan 50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100’s)
RxVAT-exempt
Zim Laboratories LimitedIndia
Jjysrinn Trading Inc.Importer: Suhitas Pharmaceuticals Inc.Trader: PSA International (Export Division of PSA Chemicals & Pharmaceuticals Pvt. Ltd.)
DRP-906-06
Apr 22, 2028
KardiostanLosartan Potassium
100 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Interphil Laboratories, Inc.Philippines
—
DRP-1454
Feb 20, 2029
KardiostanLosartan Potassium
50 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's); Alu/Clear PVC Blister Pack x 10's as Physician sample (Box of 10's); Alu/Clear PVC Blister Pack x 2's as Physician sample (Box of 2's)
RxVAT-exempt
Interphil Laboratories, Inc.Philippines
—
DRP-1456
Mar 19, 2029
KenzarLosartan Potassium
100 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
The ACME Laboratories LimitedBangladesh
Bell-Kenz Pharma Inc.Importer: Euro Generics International Phils., Inc.
DRP-5934
Dec 3, 2028
KenzarLosartan (as Potassium)
50 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
The ACME Laboratories LimitedBangladesh
Bell-Kenz Pharma Inc.Importer: Euro Generics International Phils., Inc.
DRP-2215
Jan 3, 2032
KhrizaacLosartan Potassium
50mg TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Merit Organics Ltd.India
Khriz Pharma Trading Inc.
DRP-18978
Oct 12, 2031
KodisarLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hiral Labs LimitedIndia
Kodi Biosciences Inc.Importer: Aglobal Care, Inc.
DRP-8058-06
Apr 29, 2031
Kodisar 100Losartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Kodi Biosciences Inc.Importer: Pharmakon Biotec Inc.
DRP-13686-11
Mar 28, 2028
KozartanLosartan Potassium
50 mg Film-Coated TabletAlu-Opaque White PVC Blister Pack x 10's (Box of 30's,50's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Konzept Convenience And Drug Store Corp.
DRP-12412-06
Aug 1, 2031
Ksart 50Losartan Potassium
50 mg Film-Coated TabletAlu/Clear PVC/PVDC Blister Pack x 10's (Box of 30's and 50's)
RxVAT-exempt
KUSUM HEALTHCARE PRIVATE LIMITEDIndia
KUSUM HEALTHCARE PRIVATE LIMITED BRANCH OFFICE
DR-XY39984
Sep 1, 2027
L-ZerprimeLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's & 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Life and Health Source Pharmaceutical Distribution Co.Importer: Pharmakon Biotec Inc.
DRP-13687-09
Mar 28, 2028
Lanzaar 50Losartan Potassium
50 mg Film-Coated TabletAlu/White PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Berlin Pharmaceutical Industry Co., Ltd.Thailand
Metro Drug, Inc.Importer: Paradigm Pharma (Philippines) CorporationTrader: Paradigm Pharma (Thailand) Co., Ltd.
DRP-13778
Feb 18, 2029
LeesartanLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hiral Labs LimitedIndia
C & S Medical Solutions Inc.Importer: Aglobal Care, Inc.
DRP-8058-07
Feb 4, 2032
Leesartan 100Losartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
C & S Medical Solutions Inc.Importer: Pharmakon Biotec Inc.
DRP-13686-08
Mar 28, 2028
LexzarLosartan Potassium
50 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
J.M. Tolmann Laboratories, Inc.Philippines
Auspicia Inc.Trader: Interhealthcare Pharmaceuticals Inc.
DRP-1216-10
Jul 30, 2028
LifetanLosartan Potassium
50 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Zim Laboratories LimitedIndia
Life and Health Source Pharmaceutical Distribution Co.Importer: Medinova Pharmaceutical Inc.
DRP-8985-06
Aug 6, 2031
LifezarLosartan Potassium
100 mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 15's (Box of 30's)
RxVAT-exempt
Sandoz Grup Saglik Urunleri Ilaclari Sanayi Ve Ticaret A.S.Turkey
Unilab, Inc.Importer: Sandoz Philippines Corporation
DRP-2184-03
Jul 7, 2029
LifezarLosartan Potassium
100 mg TabletWhite Opaque Aluminum Blister Pack x 10's (Box of 50's)
RxVAT-exempt
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, Inc.
DRP-2676
Jun 6, 2027
LifezarLosartan Potassium
50 mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 10's and 15's (Box of 30's)
RxVAT-exempt
Sandoz Grup Saglik Urunleri Ilaclari Sanayi Ve Tiracet A.S. (Gebze 2)Turkey
UNILAB, Inc.Importer: Sandoz Philippines Corporation
DRP-2183-03
Jan 26, 2030
LifezarLosartan Potassium
50 mg TabletWhite Opaque Aluminum Blister Pack x 10's (Box of 50's)
RxVAT-exempt
Amherst Laboratories, Inc.Philippines
Trader: UNILAB, Inc.
DRP-2675
Jun 6, 2027
LipewinLosartan (as Potassium)
50 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
XL Laboratories Pvt. Ltd.India
Applied Pharmaceutical DistributionImporter: Ambica International Corporation
DRP-3183
Jun 7, 2037
LO-KLosartan Potassium
50mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
PSA Chemicals & Pharmaceuticals Pvt. Ltd.India
Suhitas Pharmaceuticals Inc.
DRP-16832
Jul 16, 2030
LodeesartLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 60's and 100's)
RxVAT-exempt
Windlas Biotech Limited (Plant-1)India
Ambicare Pharmaceuticals Inc.Importer: Ambica International CorporationTrader: Mankind Pharma Ltd.
DRP-5960-03
Feb 4, 2028
LorcareLosartan Potassium
100 mg Film-Coated TabletAlu / Opaque White PVC Blister Pack x 10's (Box of 30's, 50's, and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Jaac Healthline Marketing
DRP-15663-04
Aug 16, 2029
LorcareLosartan Potassium
50 mg Film-Coated TabletAlu-Opaque White PVC Blister Pack x 10's (Box of 30's, 50's, and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Jaac Healthline Marketing
DRP-12412-13
Jul 14, 2031
LortanLosartan Potassium
50 mg TabletAlu-Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Biopharma Laboratories LimitedBangladesh
JF Draf Pharmaceuticals Corporation
DRP-3306
Oct 12, 2031
LortavonLosartan Potassium
100 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 10's (Box of 30's, 50's 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-15663-06
Aug 16, 2029
LortavonLosartan Potassium
50 mg Film-Coated TabletAlu-Opaque White PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories, Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-12412-16
Aug 3, 2031
Losa Speed 100Losartan Potassium
100 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Interphil Laboratories, Inc.Philippines
Speed Med Pharmaceuticals Inc.
DRP-1454-07
Feb 20, 2029
Losaar 100Losartan Potassium
100 mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 10's Box of 30's and 100's
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
AMB HK Enterprises, Inc.
DRP-8523
Oct 25, 2029
Losaar 50Losartan Potassium
50 mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 10's Box of 30's and 100's
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
AMB HK Enterprises Inc.
DRP-8522
Oct 25, 2029
LosablocLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation
DRP-5458-01
Aug 18, 2029
LosacarLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 70's)
RxVAT-exempt
Cadila Healthcare LimitedIndia
Zydus Healthcare Philippines, Inc.
DRP-1230
Jan 30, 2028
Losacar 100Losartan Potassium
100 mg Film-Coated TabletAlu/PVDC/PVC Blister Pack x 10's (Box of 100's); Alu/PVDC/PVC Blister Pack x 10's (Box of 10's as Physician's Sample)
RxVAT-exempt
Cadila Healthcare LimitedIndia
Zydus Healthcare Philippines, Inc.
DRP-7348
Feb 8, 2028
Losacraft-50Losartan Potassium
50 mg Film-coated tabletAlu/ Alu Blister pack x 10's (Box of 100's)
RxVAT-exempt
Mankind Pharma Limited (Unit II)India
Ellebasy Medicale Group, Inc.Importer: I.E. Medica, Inc.
DRP-8657
Jan 31, 2030
LosacuraLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
PSA Chemicals & Pharmaceuticals Pvt. Ltd.India
RVM Pharma & Medical Supplies DistributionImporter: Orange Biotec Inc.
DRP-15448-04
Jul 10, 2029
LosafilLosartan Potassium
50 mg Film-Coated TabletAlu/ PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
J.M. Tolmann Laboratories, Inc.Philippines
Filadams Pharma, Inc.Trader: Interhealthcare Pharmaceuticals, Inc.
DRP-1216-12
Jul 30, 2028
Losagan-50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-5458
Aug 18, 2029
Losagen 50Losartan Potassium
50 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hetero Labs Limited (Unit V)India
Camber Pharmaceuticals, Inc.
DRP-6891
Mar 11, 2027
LosagetLosartan Potassium
50 mg Film-Coated TabletAlu/PVC Blister Pack x 10's Box of 100's
RxVAT-exempt
Hetero Labs Limited (Unit-V)India
2MG IncorporatedImporter: Camber Pharmaceuticals, Inc.
DRP-6891-01
Mar 11, 2027
LosagoldLosartan Potassium
100 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 10's (Box of 30's, 50's, 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Brilliantmeed, Inc.
DRP-15663-08
Aug 16, 2029
Losakind-50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mankind Pharma Limited (Unit II)India
Ambica International Corporation
DRP-12057
Jun 3, 2032
Losakind-50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 60’s); Alu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Windlas Biotech Limited (Plant-1)India
Ambica International CorporationTrader: Mankind Pharma Ltd.
DRP-5960
Feb 4, 2028
Losamar-100Losartan Potassium
100 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 10's (Box of 30's, 50's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Triple 888 Medical And Pharma Inc.
DRP-15663-05
Aug 16, 2029
LOSAMAR-50Losartan Potassium
50 mg Film-Coated TabletAlu-Opaque White PVC Blister Pack x 10's (Box of 30's, 50's, and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Triple 888 Medical And Pharma Inc.
DRP-12412-15
Aug 3, 2031
LosamaxLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Medicamen Biotech LimitedIndia
Pharmastar Int'l Trading Corp.
DRP-17425
Dec 15, 2030
Losan 50Losartan Potassium
50mg TabletAlu/PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Kopran LimitedIndia
Despina Pharma, Inc.
DRP-13056
Nov 23, 2027
Losangio 50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's); Alu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Diafarm Inc.Trader: Endurance Healthcare Ltd.
DRP-5188
Oct 25, 2028
LosaprimeLosartan Potassium
100 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Emil Pharmaceutical Industries Pvt. Ltd.India
Diafarm Inc.Importer: Ambica International CorporationTrader: Chempro Pharma Pvt. Ltd.
DRP-10067-03
May 26, 2028
Losar-50Losartan potassium
50 mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Unichem Laboratories Limited (Unit II)India
Ambica International Corporation
DRP-4834
Oct 18, 2028
LosaramLosartan Potassium
100 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Emil Pharmaceutical Industries Pvt. Ltd.India
Federal Pharmaceuticals Inc.Importer: Ambica International CorporationTrader: Chempro Pharma Pvt. Ltd.
DRP-10067-04
May 26, 2028
LosarbetLosartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Better Option Pharmaceuticals, Inc.Importer: Pharmakon Biotec Inc.
DRP-13686-10
Mar 28, 2028
LosarcureLosartan Potassium
100 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Prodrom Nutritionals, IncorporatedImporter: Ambica International Corporation
DRP-4693-10
Sep 6, 2028
LosargardLosartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Innogen Pharmaceuticals, Inc.
DRP-6406
May 30, 2027
LosargardLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 30's
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Innogen Pharmaceuticals, Inc.
DRP-6407
Jun 22, 2027
LosarkLosartan Potassium
100 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
777 Red Pharma Inc.Importer: Philgen Pharmaceuticals, Inc.
DRP-1882-03
Mar 4, 2027
Losarkip 100Losartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Kipson Pharmaceutical TradingImporter: Pharmakon Biotec Inc.
DRP-13686-12
Mar 28, 2028
Losarkip 50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Kipson Pharmaceutical TradingImporter: Pharmakon Biotec Inc.
DRP-13687-16
Mar 28, 2028
LosarloLosartan Potassium
100 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Medibios Laboratories Pvt.Ltd.India
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International CorporationTrader: Chempro Pharma Pvt. Ltd.
DRP-10067-02
May 26, 2028
LosarnielLosartan potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Speed Cure PharmaImporter: Ambica International Corporation
DRP-6453-04
Nov 27, 2030
LosartLosartan Potassium
50 mg Film-coated TabletAlu/PVC Blister Pack x 10's (Box of 100's and Box of 30's for DOH)
RxVAT-exempt
Concept Pharmaceuticals Ltd.India
Phil Pharmawealth, Inc.
DR-XY38577
Oct 5, 2030
LosartapLosartan Potassium
100 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 10's (Box of 30's, 50's, 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-15663-02
Aug 16, 2029
LosartapLosartan Potassium
50 mg Film-Coated TabletAlu-Opaque White PVC Blister Pack x 10's (Box of 30's, 50's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-12412-01
Aug 1, 2031
LosartfixLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 60's and 100's)
RxVAT-exempt
Windlas Biotech Private Limited (Plant-1)India
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International CorporationTrader: Mankind Pharma Ltd.
DRP-5960-04
Feb 4, 2028
Losartrixx 100Losartan Potassium
100 mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc.
DRP-8523-02
Oct 25, 2029
Losartrixx 50Losartan Potassium
50 mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 10’s Box of 30’s and 100’s
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc.
DRP-8522-02
Oct 25, 2029
Losarx 100Losartan Potassium
100 mg Film-Coated TabletsAlu-Alu Blister Pack of 10's (Box of 100's).
RxVAT-exempt
Globela Pharma Pvt. Ltd.India
AMB HK Enterprises Inc.
DRP-15533
Jul 31, 2029
Losarx 100Losartan (as Potassium)
100mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 10 tablets (Box of 10 blister packs x 10 tablets)
RxVAT-exempt
Globela Pharma Private LimitedIndia
Amb Hk Enterprises Inc.Importer: AMB HK Enterprises Inc.
DRP-13557
Mar 9, 2028
Losarx 50Losartan Potassium
50 mg Film-Coated TabletAlu-Alu Blister Pack of 10's (Box of 100's)
RxVAT-exempt
Globela Pharma Pvt. Ltd.India
AMB HK Enterprises Inc.
DRP-15534
Jul 31, 2029
Losarx 50Losartan (as Potassium)
50mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 10 tablets (Box of 10 blister packs x 10 tablets)
RxVAT-exempt
Globela Pharma Private LimitedIndia
Amb Hk Enterprises Inc.Importer: AMB HK Enterprises Inc.
DRP-13556
Mar 9, 2028
LosaSpeed 50Losartan Potassium
50 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's); Alu/Clear PVC Blister Pack x 10's as Physician sample (Box of 10's); Alu/Clear PVC Blister Pack x 2's as Physician sample (Box of 2's)
RxVAT-exempt
Interphil Laboratories, Inc.Philippines
Speed Med Pharmaceuticals Inc.
DRP-1456-06
Mar 19, 2029
Losastal-50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambica International Corporation
DRP-5040
Jan 7, 2029
LosaverLosartan Potassium
50 mg Film-Coated TabletAlu / Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Rule Med Pharma Corp.Importer: Pharmakon Biotec Inc.
DRP-13687-12
Mar 28, 2028
Losawin-100Losartan Potassium
100 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Ambica International Corporation
DRP-4693
Sep 6, 2028
Losawin-50Losartan potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Ambica International Corporation
DRP-6453
Nov 27, 2030
LosiumLosartan (as potassium)
50 mg Film-Coated TabletAluminum Strip Foil x 10's Box of 100's
RxVAT-exempt
Cadila Pharmaceuticals Ltd.India
Ambica International Corporation
DRP-5733
Mar 5, 2029
LosmacLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 50’s and 100’s)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Suhitas Pharmaceuticals Inc.Trader: Mac Heal Laboratories Ltd.
DRP-3303
Oct 11, 2031
LossiutabLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s Box of 100’s
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-5040-05
Jan 7, 2029
LOSTANLosartan Potassium
100 mg Film-Coated TabletPVC / ALU BLISTER PACK X 10'S (BOX OF 100'S)
RxVAT-exempt
J.M. TOLMANN LABORATORIES INC.Philippines
GOLD LIFE DISTRIBUTION PHILS. INC.Trader: INTERHEALTHCARE PHARMACEUTICALS INC.
DRP-1100-09
Dec 17, 2029
LostanLosartan Potassium
50 mg Film-Coated TabletAlu/PVC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
J.M. TOLMANN LABORATORIES INC.Philippines
GOLD LIFE DISTRIBUTION PHILS. INC.Trader: INTERHEALTHCARE PHARMACEUTICALS INC.
DRP-1216-11
Jul 30, 2028
LostarLosartan Potassium
50 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 100’s)
RxVAT-exempt
Zim Laboratories LimitedIndia
Starpharm, Inc.Importer: Suhitas Pharmaceuticals Inc.Trader: PSA International (Export Division of PSA Chemicals & Pharmaceuticals Pvt. Ltd.)
DRP-906-01
Apr 22, 2028
Lostar 100Losartan Potassium
100 mg Film-Coated TabletAlu / Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Emil Pharmaceutical Industries Pvt. Ltd.India
Starpharm, Inc.Importer: Ambica International CorporationTrader: Chempro Pharma Pvt. Ltd.
DRP-10067-05
May 26, 2028
Lostar-100Losartan Potassium
100 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Starpharm, Inc.Importer: Ambica International Corporation
DRP-4693-02
Sep 6, 2028
Lostar-50Losartan Potassium
50 mg Film-Coated TabletAlu-Opaque White PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Starpharm, Inc.
DRP-12412-12
Dec 13, 2031
LotaseLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Randril International Co., Inc.
DR-XY33358
May 23, 2027
LotaseLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Randril International Co., Inc.
DRP-15625
May 23, 2027
LoxartLosartan Potassium
50 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
J.M. Tolmann Laboratories, Inc.Philippines
Basic Pharmaceutical CorporationTrader: Interhealthcare Pharmaceuticals Inc.
DRP-1216-09
Jul 30, 2028
Loza 50Losartan Potassium
50 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
The Madras PharmaceuticalsIndia
Better Option Pharmaceuticals, IncImporter: Synergen Pharma Inc.Trader: Synergen Asia Pte. Ltd.
DRP-1767
Feb 10, 2029
LozaarLosartan Potassium
50 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Totalcare Pharma Inc.
DRP-982
May 28, 2027
LozakLosartan (as Potassium)
100 mg TabletAlu/Amber PVC Blister Pack x 10's (Box of 30's); Alu/Amber PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
LIFESQUARE LABORATORIES INCPhilippines
—
DRP-4724
Sep 17, 2029
LozakLosartan Potassium
50 mg TabletAlu-White Opaque PVC Blister Pack x 10's Box of 30's and 100's (with blue packaging design/layout); Alu-White Opaque PVC Blister Pack x 10's Box of 30's (with green packaging design/layout with Philippine Government - "DOH Property Not for Sale")
RxVAT-exempt
LifeSquare Laboratories, Inc.Philippines
—
DRP-4706
Sep 13, 2031
Lozark 50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s, 60’s, 90’s and 100’s)
RxVAT-exempt
Sai Parenterals LtdIndia
Roymed PharmaceuticalImporter: Nelpa Lifesciences, Inc.
DRP-12532-04
Jan 23, 2031
Lozart 50Losartan potassium
50mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Despina Pharma Inc.
DRP-16743
Jul 4, 2030
Lozend 100Losartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's & 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Hale Medipoint Corp.Importer: Pharmakon Biotec Inc.
DRP-13686-06
Mar 28, 2028
Lozend 50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's & 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Hale Medipoint Corp.Importer: Pharmakon Biotec Inc.
DRP-13687-06
Mar 28, 2028
LoztafixxLosartan Potassium
100 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10’s (Box of 30’s and 100’s)
RxVAT-exempt
Emil Pharmaceutical Industries Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International CorporationTrader: Chempro Pharma Pvt. Ltd.
DRP-10067-09
May 26, 2028
MabisartanLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
PSA Chemicals & Pharmaceuticals Pvt. Ltd.India
Medconcern Drugs and General Merchandise Inc.Importer: Orange Biotec Inc.
DRP-15448-02
Jul 10, 2029
MalsarLosartan Potassium
50 mg TabletAlu/PVC/PVDC Blister Pack x 10's (Box of 10's and 100's)
RxVAT-exempt
PharmEvo (Pvt.) Ltd.Pakistan
Malyka International Trading Corp.Importer: Accesspoint International Trading Inc.
DRP-5768-01
Dec 4, 2028
MedzartLosartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Medhaus Pharma Inc.
DR-XY43008
Nov 22, 2028
MedzartLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Medhaus Pharma Inc.
DR-XY43007
Nov 22, 2028
MelsartanLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
RM Lorenzo Pharma & Distribution Inc.Importer: Pharmakon Biotec Inc.
DRP-13687-14
Mar 28, 2028
MoxifastLosartan Potassium
100 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation
DRP-4693-07
Sep 6, 2028
MyotanLosartan Potassium
50 mg TabletFoil Strip x 10's (Box of 30's and 100's)
RxVAT-exempt
Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals and Pharmaceuticals Limited)India
JBCPL Philippines Inc.
DRP-841
May 4, 2027
MysartanLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Synmedic LaboratoriesIndia
Primera Pharma CorporationImporter: Ambica International Corporation
DRP-2591-03
Jul 31, 2028
MyzarLosartan (as Potassium)
100 mg Film-Coated TabletPVC-PVDC-Alu Blister Pack x 14's (Box of 28's)
RxVAT-exempt
Intas Pharmaceuticals LimitedIndia
Phil Pharmawealth, Inc.Importer: Singapore Genebio Inc.
DR-XY38637
Oct 15, 2030
MyzarLosartan (as Potassium)
50 mg Film-coated TabletPVC-PVDC-Alu Blister Pack x 14's (Box of 28's)
RxVAT-exempt
Intas Pharmaceuticals LimitedIndia
Phil Pharmawealth, inc.Importer: Singapore Genebio, Inc.
DR-XY38638
Oct 15, 2030
NatrasolLosartan Potassium
100 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 10's and 100's)
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
Philgen Pharmaceuticals Inc.
DRP-1882
Mar 4, 2027
NatrasolLosartan Potassium
50 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's); Alu/Clear PVC Blister Pack x 10's (Box of 30's) [For DOH Use Only]
RxVAT-exempt
Centurion Laboratories Pvt. Ltd.India
Philgen Pharmaceuticals, Inc.
DRP-1884
Sep 14, 2027
Natrasol 100Losartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Dagon Pharmaceuticals Pvt. Ltd.India
Philgen Pharmaceuticals Inc.
DRP-15133
May 8, 2029
NatrazolLosartan Potassium
100 mg TabletAlu/White Opaque PVC Blister Pack x 20's Box of 100’s; Alu/White Opaque PVC Blister Pack x 10's Box of 30’s [Property of Department of Health]
RxVAT-exempt
Diamond Laboratories Inc.Philippines
Rilem Pharma Corp.
DRP-7116
Nov 13, 2027
NatrazolLosartan Potassium
50 mg TabletAlu/White Opaque PVC Blister Pack x 20's (Box of 100's); Alu/White Opaque PVC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Diamond Laboratories Inc.Philippines
Rilem Pharma Corp.
DRP-7115
Nov 13, 2027
NavsartanLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30's and 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
JNC Pharmaceuticals CorporationImporter: Pharmakon Biotec, Inc.
DRP-13687-20
Mar 28, 2028
NeosartanLosartan Potassium
100mg Film-Coated TabletAlu/Pvc Blister Pack X 10's (Box of 30's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Trader: GX International, Inc.
DR-XY36844
Oct 20, 2030
NeosartanLosartan Potassium
50 mg Film-Coated TabletAlu/White Pvc Blister Pack X 10's (Box of 30's and 300's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Trader: GX International, Inc.
DR-XY37290
Jan 4, 2030
Neozart 50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 100's)
RxVAT-exempt
Zim Laboratories LimitedIndia
Neo Care Philippines, Inc.Importer: Medinova Pharmaceutical Inc.
DRP-8985-13
Jul 21, 2030
NewsartanLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister pack x 10's (Box of 100's)
RxVAT-exempt
Zim Laboratories LimitedIndia
New Seammed Inc.Importer: Medinova Pharmaceutical Inc.
DRP-8985-08
Aug 18, 2031
NexartLosartan (as Potassium)
50mg TabletAlu/Red PVC Blister Pack x 20's (Box of 100's)
RxVAT-exempt
Drugmaker's Laboratories, Inc.Philippines
Chmi Pharma, Inc.
DRP-7209-02
Sep 19, 2037
NipartanLosartan Potassium
50 mg TabletAlu/Alu Blister Pack x 10''s (Box of 30's and 100's)
RxVAT-exempt
Micro Labs LimitedIndia
Brown & Burk Philippines Inc.
DRP-897
Oct 22, 2029
NoneLosartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Bulacan
Trader: Dyna Drug Corporation
DR-XY39433
May 9, 2031
NoneLosartan potassium
100 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100’s)
RxVAT-exempt
Sai Parenterals Ltd.#51 TSIIC Industrial Park Hyderabad-Warangal Highway Bhongir Telangana 508116 India
PharmaVital Corp.Importer: Nelpa Lifesciences, Inc.
DRP-10666-02
Apr 2, 2030
NoneLosartan Potassium
100 mg Film-Coated TabletPVC Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
J.M. Tolmann Laboratories, Inc.Philippines
Gamot Philippines, Inc.Trader: Interhealthcare Pharmaceuticals Inc.
DRP-1100-07
Dec 17, 2029
NoneLosartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Zydus Healthcare Philippines Inc.Importer: Pharmakon Biotec Inc.
DRP-13686-01
Mar 28, 2028
NoneLosartan Potassium
100 mg Film-Coated TabletAlu/PVC Blister Pack x 10's Box of 10's and 100's
RxVAT-exempt
Interphil Laboratories, Inc.Philippines
Rose Pharmacy, Incorporated
DRP-1454-03
Feb 20, 2029
NoneLosartan Potassium
100 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Interphil Laboratories, Inc.Philippines
Neodrug Inc.
DRP-1454-04
Feb 20, 2029
NoneLosartan Potassium
100 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Interphil Laboratories, Inc.Philippines
St. Joseph Drugstore
DRP-1454-06
Feb 20, 2029
NoneLosartan potassium
100 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Ratnatris Pharmaceuticals Private LimitedIndia
GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc.
DRP-16506-02
Apr 2, 2030
NoneLosartan potassium
100 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Ratnatris Pharmaceuticals Private LimitedIndia
MED4UImporter: Medinova Pharmaceutical Inc.
DRP-16506-04
Apr 2, 2030
NoneLosartan Potassium
100 mg Film-Coated TabletAlu/White PVDC Blister Pack x 10's (Box of 30's, 50's, and 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Actimed, Inc.
DRP-1667-08
Feb 9, 2037
NoneLosartan Potassium
100 mg Film-Coated TabletAlu/Alu blister pack x 10’s (Box of 100’s)
RxVAT-exempt
Saga Lifesciences LimitedIndia
Qualifirst Health Inc.Importer: Hexagon Pharmaceuticals
DRP-16773-01
Dec 14, 2026
NoneLosartan Potassium
100 mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 10's; Alu/PVC/PVDC Blister Pack x 15's Box of 30's
RxVAT-exempt
Sandoz Grup Saglik Urunleri Ilacari Sanayi Ve Tiracet A.S. (Gebze 2)Turkey
Ritemed Phils., Inc.Importer: Sandoz Philippines Corporation
DRP-2184-02
Jul 7, 2029
NoneLosartan Potassium
100 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Actimed, Inc.Importer: Ambica International Corporation
DRP-4693-04
Sep 6, 2028
NoneLosartan Potassium
100 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Bewise Trading Corp. doing business under the name and style of Pharmaplus Generic & Branded Dug Distributor & Medical SuppliesImporter: Ambica International Corporation
DRP-4693-13
Sep 6, 2028
NoneLosartan Potassium
100 mg Film-Coated TabletOpaque White PVC/Aluminum Blister Pack x 10's (Box of 60's)
RxVAT-exempt
Pascual Laboratories, Inc.,Philippines
—
DRP-5096
Dec 7, 2030
NoneLosartan Potassium
100 mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
Farmacia ni Dok, Inc.Importer: AMB HK Enterprises Inc.
DRP-8523-03
Oct 25, 2029
NONELosartan Potassium
100 mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
Actimed, Inc.Importer: AMB HK Enterprises Inc.
DRP-8523-05
Oct 25, 2029
NoneLosartan Potassium
100 mg TabletWhite Opaque Aluminum Blister Pack x 10's (Box of 50's)
RxVAT-exempt
Amherst Laboratories, Inc.Philippines
Ritemed Phils., Inc.Trader: UNILAB, Inc.
DRP-2676-02
Jun 6, 2027
NoneLosartan Potassium
50 mg Film Coated TabletBlister Pack x 10's (Box of 100's)
RxVAT-exempt
Flamingo Pharmaceuticals Ltd.India
Qualifirst Health Inc.Importer: Hexagon Pharmaceuticals
DRP-722-04
Oct 8, 2027
NoneLosartan Potassium
50 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Dyna Drug Corporation
DR-XY39432
May 9, 2031
NoneLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100’s)
RxVAT-exempt
Sai Parenterals Ltd.TSIIC Industrial Park Hyderabad-Warangal Highway Bhongir Telangana 508116 India
PharmaVital Corp.Importer: Nelpa Lifesciences, Inc.
DRP-12532-03
Jan 23, 2031
NoneLosartan Potassium
50 mg Film-Coated TabletWhite PVDC Blister Pack x 10’s (Box of 30’s, 50’s and 100’s)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
—
DRP-128
Oct 10, 2030
NoneLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Zydus Healthcare Philippines Inc.Importer: Pharmakon Biotec Inc.
DRP-13687-01
Mar 28, 2028
NoneLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's & 100's)
RxVAT-exempt
—India
Alkem Laboratories CorporationImporter: Pharmakon Biotec Inc.
DRP-13687-11
Mar 28, 2028
NoneLosartan potassium
50 mg Film-coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Novagen Healthcare Private LimitedIndia
Actimed, Inc.Importer: I.E. Medica, Inc.Trader: Plethico Laboratories Pvt. Ltd.
DRP-14267-01
Jun 30, 2028
NoneLosartan Potassium
50 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Interphil Laboratories, Inc.Philippines
Rose Pharmacy, Incorporated
DRP-1456-02
Mar 19, 2029
NoneLosartan Potassium
50 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's Box of 100's
RxVAT-exempt
Interphil Laboratories, Inc.Philippines
Neodrug Inc.
DRP-1456-03
Mar 19, 2029
NoneLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
PSA Chemicals & Pharmaceuticals Pvt. Ltd.India
Better Option Pharmaceuticals, Inc.Importer: Orange Biotec Inc.
DRP-15448-03
Jul 10, 2029
NoneLosartan Potassium
50 mg Film-Coated TabletAlu-Alu Blister Pack of 10's (Box of 30's); Alu-Alu Blister Pack of 10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Miracare CorporationImporter: Teramedix Pharma Trading Inc.
DRP-16161-01
Dec 4, 2029
NoneLosartan Potassium
50 mg Film-Coated TabletAlu-Alu Blister Pack x 10’s (Box of 30’s)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Cyden Medicale Trading Inc.Importer: Teramedix Pharma Trading Inc.
DRP-16161-04
Dec 4, 2029
NoneLosartan Potassium
50 mg FIlm-Coated TabletAlu/PVC/PVDC Blister Pack x 10's (Box of 30's); Alu/PVC/PVDC Blister Pack x 15's (Box of 30's)
RxVAT-exempt
Sandoz Grup Saglik Urunleri Ilaclari Sanayi Ve Tiracet A.S. (Gebze 2)Turkey
Ritemed Phils., Inc.Importer: Sandoz Philippines Corporation
DRP-2183-02
Jan 26, 2030
NoneLosartan (as Potassium)
50 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
XL Laboratories Pvt. Ltd.India
Actimed, Inc.Importer: Ambica International Corporation
DRP-3183-02
Jun 7, 2027
NoneLosartan (as Potassium)
50 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
XL Laboratories Pvt. Ltd.India
Ritemed Phils., Inc.Importer: Ambica International Corporation
DRP-3183-05
Jun 7, 2027
NoneLosartan Potassium
50 mg Film-Coated TabletWhite Opaque PVC/Alu/Alu Blister Pack of 14's (Box of 28's)
RxVAT-exempt
IPCA Laboratories LimitedIndia
International Pharmaceuticals, Inc.Importer: Blue Global (FZE)
DRP-3971-02
Mar 15, 2030
NoneLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation
DRP-5040-06
Jan 7, 2029
NoneLosartan Potassium
50 mg Film-Coated TabletOpaque white PVC/Aluminum Blister Pack x 10's (Box of 60's)
RxVAT-exempt
Pascual Laboratories, Inc.,Philippines
—
DRP-5095
Dec 7, 2030
NoneLosartan Potassium
50 mg Film-Coated TabletOpaque white PVC/Aluminum Blister Pack x 10's (Box of 60's)
RxVAT-exempt
Pascual Laboratories, Inc.,Philippines
Watsons Personal Care Stores (Philippines), Inc.
DRP-5095-01
Feb 7, 2032
NoneLosartan Potassium
50 mg Film-Coated TabletOpaque white PVC/Aluminum Blister Pack x 10's (Box of 60's)
RxVAT-exempt
Pascual Laboratories, Inc.,Philippines
Ritemed Phils., Inc.
DRP-5095-03
Feb 3, 2032
NoneLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
AGB Pharmaceutical Trading and Consultancy CorporationImporter: Diafarm Inc.Trader: Endurance Healthcare Ltd.
DRP-5188-01
Oct 25, 2028
NoneLosartan Potassium
50 mg Film-Coated TabletAlu/White PVDC Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Boie Incorporated
DRP-5916-01
Dec 23, 2029
NoneLosartan Potassium
50 mg Film-Coated TabletPVC/PVDC Film-Blister x 10’s (Box of 30’s)
RxVAT-exempt
Agio Pharmaceuticals LimitedIndia
Providencia Medica, Inc.Importer: Ambica International Corporation
DRP-6409
May 13, 2031
NoneLosartan potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-6453-01
Apr 1, 2037
NoneLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Airlife International Trading CorporationImporter: Ambica International Corporation
DRP-6453-06
Nov 27, 2030
NoneLosartan potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Bewise Trading Corp. Doing business under the name & style of Pharmaplus Generic & Branded Drug Distributor & Medical SuppliesImporter: Ambica International Corporation
DRP-6453-07
Nov 27, 2030
NoneLosartan Potassium
50 mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 10's Box of 30's and 100's
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
Farmacia ni Dok, Inc.Importer: AMB HK Enterprises Inc.
DRP-8522-04
Oct 25, 2029
NoneLosartan Potassium
50 mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 10's Box of 30's and 100's
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
Dyna Drug CorporationImporter: AMB HK Enterprises Inc.
DRP-8522-05
Oct 25, 2029
NoneLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Zim Laboratories LimitedIndia
MED4UImporter: Medinova Pharmaceutical Inc.
DRP-8989-15
Jul 21, 2030
NoneLosartan Potassium
50 mg Film-coated tabletBlister pack x 10's (Box of 100's)
RxVAT-exempt
Plethico Pharmaceuticals Ltd.India
Actimed, Inc.Importer: I.E. Medica, Inc.Trader: Wiscon Pharmaceuticals Ltd.
DRP-996-03
Nov 12, 2027
NoneLosartan Potassium
50 mg TabletWhite Opaque Aluminum Blister Pack x 10's (Box of 50's)
RxVAT-exempt
Amherst Laboratories, Inc.Philippines
Ritemed Phils., Inc.Trader: UNILAB, Inc.
DRP-2675-02
Jun 6, 2027
NoneLosartan (as Potassium)
50 mg TabletAlu/Red PVC Blister pack x 20's (Box of 100's)
RxVAT-exempt
Drugmaker's Laboratories IncPhilippines
TGP Pharma Inc.
DRP-7209-01
Sep 17, 2031
NoneLosartan Potassium
50 mg TabletFoil Strip x 10’s (Box of 100’s)
RxVAT-exempt
Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals and Pharmaceuticals Limited)India
Actimed, Inc.Importer: Ambica International Corporation
DRP-841-04
May 4, 2027
NovasartanLosartan potassium
100 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Ratnatris Pharmaceuticals Private Limited.India
Medinova Pharmaceutical Inc
DRP-16506
Apr 2, 2030
NovasartanLosartan Potassium
50 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Ratnaris Pharmaceuticals Private LimitedIndia
Medinova Pharmaceutical Inc.
DRP-18965
Oct 8, 2031
NovasartanLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister pack x 10's (Box of 100's)
RxVAT-exempt
Zim Laboratories LimitedIndia
Medinova Pharmaceutical Inc.
DRP-8985
Jul 21, 2030
OranzarLosartan Potassium
50 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 100’s)
RxVAT-exempt
Zim Laboratories LimitedIndia
Orange Biotec Inc.Importer: Suhitas Pharmaceuticals Inc.Trader: PSA International (Export Division of PSA Chemicals & Pharmaceuticals Pvt. Ltd.)
DRP-906-05
Apr 22, 2028
Parten-50Losartan Potassium
50 mg TabletAlu-clear PVC Blister Pack x 10’s (Box of 1's)
RxVAT-exempt
JAYSON PHARMACEUTICALS LTD.Bangladesh
AGLOBAL CARE, INC.
DRP-4635
Feb 1, 2028
PillsartLosartan Potassium
100 mg Film-Coated TabletAlu/ Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Emil Pharmaceutical Industries Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International CorporationTrader: Chempro Pharma Pvt. Ltd.
DRP-10067-06
May 26, 2028
PotazarLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
D'Conner PharmaImporter: Pharmakon Biotec Inc.
DRP-13687-10
Mar 28, 2028
Presartan-100Losartan Potassium
100 mg Film-Coated TabletAlu/White Opaque PVC Blister Pack x 14's (Box of 28's); Alu/White Opaque PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Ipca Laboratories LimitedIndia
Blue Global (FZE)
DRP-3902
Sep 7, 2031
Presartan-50Losartan Potassium
50 mg Film-Coated TabletWhite Opaque PVC/Alu/Alu Blister Pack of 14's (Box of 28's); White Opaque PVC/Alu/Alu Blister Pack of 10's (Box of 30's and 100's)
RxVAT-exempt
Ipca Laboratories LimitedIndia
Blue Global (FZE)
DRP-3971
Mar 15, 2030
PrestanLosartan Potassium
100 mg Film-Coated TabletAlu/White PVDC Blister Pack x 10's Box of 30's, 50's, and 100's
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Actimed, Inc.
DRP-1667
Aug 11, 2030
PrestanLosartan potassium
50 mg Film-Coated TabletAlu-White PVC/PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
—
DRP-15156
May 15, 2029
PrestanLosartan Potassium
50 mg Film-Coated TabletAlu/White PVDC Blister Pack x 10's (Box of 30's, 50's and 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Actimed, Inc.
DRP-5916
Dec 23, 2029
ProlostanLosartan Potassium
100 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Chempro Pharma Private LimitedIndia
Jjysrinn Trading Inc.Importer: Ambica International Corporation
DRP-10067
May 26, 2028
ProvizarLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Providencia Medica Inc.Importer: Ambica International Corporation
DRP-5040-07
Jan 7, 2029
ProzartLosartan Potassium
50 mg TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lark Laboratories (India) Ltd.India
D&G Pharma
DR-XY36955
Nov 10, 2030
Prozart 50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s)
RxVAT-exempt
Synmedic LaboratoriesIndia
D&G PharmaImporter: Ambica International Corporation
DRP-2591-08
Jul 31, 2028
Q-PidLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Synmedic LaboratoriesIndia
Quad-Gen PharmaceuticalsImporter: Ambica International Corporation
DRP-2591-05
Jul 31, 2028
Q-PidLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s Box of 100’s
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Quad-Gen PharmaceuticalsImporter: Ambica International Corporation
DRP-5040-03
Jan 7, 2029
Quezar 100Losartan Potassium
100 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Guimhealth Pharmaceutical Distributor and DrugstoreImporter: Ambica International Corporation
DRP-4693-06
Sep 6, 2028
Quezar 50Losartan potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Guimhealth Pharmaceutical Distributor and DrugstoreImporter: Ambica International Corporation
DRP-6453-02
Nov 27, 2030
QxarLosartan Potassium
50 mg Film-Coated TabletAlu/White PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Trader: Healthlink 211 Pharma, Inc.
DR-XY38659
Oct 18, 2030
RaptrasolLosartan Potassium
100 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 10's (Box of 30's, 50's, 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-15663-01
Aug 16, 2029
RaptrasolLosartan Potassium
50 mg Film-Coated TabletAlu-Opaque White PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-12412-05
Jul 23, 2031
RapzarLosartan Potassium
100 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 10's (Box of 30's, 50's, 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-15663-03
Aug 16, 2029
RapzarLosartan Potassium
50 mg Film-Coated TabletAlu-Opaque White PVC Blister Pack x 10's (Box of 30's, 50's, and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
St. Raphael Archangel Pharmaceutical Product Distribution
DRP-12412-02
Sep 22, 2031
RegisartLosartan Potassium
100 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10’s (Box of 30’s and 100’s)
RxVAT-exempt
Emil Pharmaceutical Industries Pvt. Ltd.India
Regimed Pharmaceutical DistributorImporter: Ambica International CorporationTrader: Chempro Pharma Pvt. Ltd.
DRP-10067-08
May 26, 2028
Regizar-100Losartan Potassium
100 mg Film-Coated TabletAlu/Opaque White PVC Blister Pack x 10's (Box of 30's, 50's, 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Regimed Pharmaceutical Distributor
DRP-15663-07
Aug 16, 2029
Regizar-50Losartan Potassium
50 mg Film-Coated TabletAlu-Opaque White PVC Blister Pack x 10's (Box of 30's, 50's, and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories, Inc.Philippines
Regimed Pharmaceutical Distributor
DRP-12412-17
Aug 3, 2031
RetasarLosartan Potassium
100 mg Film-Coated TabletAlu /Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Emil Pharmaceutical Industries Pvt. Ltd.India
Reta DrugImporter: Ambica International CorporationTrader: Chempro Pharma Pvt. Ltd.
DRP-10067-01
May 26, 2028
RetasarLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hiral Labs LimitedIndia
Reta DrugImporter: Aglobal Care, Inc.
DRP-8058-04
Apr 29, 2031
RetasarcLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
PSA Chemicals & Pharmaceuticals Pvt. Ltd.India
Reta DrugImporter: Orange Biotec Inc.
DRP-15448-01
Jul 10, 2029
RetazarLosartan Potassium
50 mg TabletAlu/PVC Blister Pack x 10’s (Box of 30’s; Box of 60's and Box of 100's)
RxVAT-exempt
Kopran LimitedIndia
Reta DrugImporter: Despina Pharma Inc.
DRP-13056-01
Nov 23, 2027
RetazartLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Zim Laboratories LimitedIndia
Reta DrugImporter: Medinova Pharmaceutical Inc.
DRP-8985-10
Aug 18, 2031
RigidonLosartan PotassiumnVariant spelling
50 mg Film Coated TabletAlu/Red PVC Blister Pack x 10's (Box of 100's)
Rx
San Marino Laboratories CorporationPhilippines
—
DRP-12332
Jul 20, 2027
Saphlor 100Losartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Genom Biotech Pvt. Ltd.India
Nelpa Lifesciences, Inc.
DRP-14961
Jan 20, 2032
Saphlor 50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Genom Biotech Pvt. Ltd.India
Nelpa Lifesciences, Inc.
DRP-14962
Jan 20, 2032
Saphlor-100Losartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's
RxVAT-exempt
Sapphire Lifesciences Pvt. Ltd.India
Nelpa Lifesciences Inc.
DRP-10666
Feb 2, 2031
Saphlor-100Losartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Sapphire Lifesciences Pvt. Ltd.India
Nelpa Lifesciences, Inc.
DRP-12531
Sep 2, 2027
Saphlor-50Losartan potassium
50 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Sai Parenterals Ltd.India
Nelpa Lifesciences, Inc.
DRP-10667
Jan 30, 2030
Saphlor-50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's, 60's, 90's and 100's)
RxVAT-exempt
Sai Parenterals Ltd.India
Nelpa Lifesciences, Inc.
DRP-12532
Jan 23, 2031
Saranto 50Losartan Potassium
50mg Film-coated tabletAlu/ White Opaque PVC/PE/PVDC Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Aurobindo Pharma Limited (Unit III)India
AAA Pharma,Inc.
DR-XY41720
Feb 22, 2028
SartanLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s Box of 30’s
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
ECE Pharmaceuticals, Inc.Importer: Ambica International Corporation
DRP-5040-01
Jan 7, 2029
Sartan 100Losartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
ECE Pharmaceuticals, Inc.Importer: Ambica International Corporation
DRP-4693-11
Sep 6, 2028
SartangoldLosartan Potassium
50 mg Film-Coated TabletAlu-Opaque White PVC Blister Pack x 10's (Box of 30's, 50's, and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories, Inc.Philippines
Brilliantmeed, Inc.
DRP-12412-18
Aug 3, 2031
Sartanova-100Losartan potassium
100 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Ratnatris Pharmaceuticals Private LimitedIndia
GA2 Pharmaceutical Inc.Importer: Medinova Pharmaceutical Inc.
DRP-16506-01
Apr 2, 2030
Sartassium-100Losartan Potassium
100 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Ambitech Biopharmaceuticals Inc.Importer: Ambica International Corporation
DRP-4693-08
Sep 6, 2028
Sartassium-50Losartan potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mediwin PharmaceuticalsIndia
Ambitech Biopharmaceuticals Inc.Importer: Ambica International Corporation
DRP-6453-05
Nov 27, 2030
Sartollen 100Losartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30's, 60's, 90's and 100's)
RxVAT-exempt
Sapphire Lifesciences Pvt. Ltd.India
Ollen Pharma Trading Inc.Importer: Nelpa Lifesciences, Inc.
DRP-12531-02
Sep 2, 2027
Sartollen 50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100's)
RxVAT-exempt
Sapphire Lifesciences Pvt. Ltd.India
Ollen Pharma TradingImporter: Nelpa Lifesciences, Inc.
DRP-12532-02
Sep 2, 2027
SaztanLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hiral Labs LimitedIndia
Medhart Pharma Inc.Importer: Aglobal Care, Inc.
DRP-8058-01
Apr 29, 2031
Shertan-100Losartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Kain’s Trading Corp.Importer: Pharmakon Biotec Inc.
DRP-13686-09
Mar 28, 2028
Shertan-50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Kain's Trading Corp.Importer: Pharmakon Biotec Inc.
DRP-13687-13
Mar 28, 2028
Spartan 50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
RL Pharma Enterprises Inc.Importer: Pharmakon Biotec Inc.
DRP-13687-07
Mar 28, 2028
StarloLosartan Potassium
100 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Saga Lifesciences LimitedIndia
Hexagon Pharmaceuticals
DRP-16773
Dec 14, 2031
StarloLosartan Potassium
100 mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 100's)
RxVAT-exempt
Saga LaboratoriesIndia
Hexagon Pharmaceuticals
DR-XY47605
Dec 14, 2026
StarloLosartan Potassium
50 mg Film Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Saga Lifesciences LimitedIndia
Hexagon Pharmaceuticals
DRP-16771
Dec 14, 2031
StarloLosartan Potassium
50 mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 100's)
RxVAT-exempt
Saga LaboratoriesIndia
Hexagon Pharmaceuticals
DR-XY47606
Dec 14, 2026
SydentanLosartan Potassium
100 mg Film-Coated TabletAlu/PVC White Opaque Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Sydenham Laboratories, Inc.Philippines
Sydenham Pharmaceuticals, Inc.
DRP-1797
Sep 29, 2029
SydentanLosartan Potassium
50 mg Film-Coated TabletAlu/White Opaque PVC Blister Pack x 10's Box of 100's
RxVAT-exempt
Sydenham Laboratories, Inc.Philippines
—
DR-XY36849
Oct 21, 2029
TanzaseLosartan Potassium
50 mg TabletAlu/PVC/PVDC Blister Pack x 10's (Box of 10's and 100's)
RxVAT-exempt
PharmEvo (Pvt.) Ltd.Pakistan
Accesspoint International Trading Inc.
DRP-5768
Dec 4, 2028
TechnozarLosartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
One Technodrug Life Sciences Inc.Importer: Pharmakon Biotec Inc.
DRP-13686-05
Mar 8, 2028
TechnozarLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
One Technodrug Life Sciences Inc.Importer: Pharmakon Biotec Inc.
DRP-13687-04
Mar 28, 2028
TenzorichLosartan Potassium
50 mg Film-Coated TabletAlu / Alu Blister Pack x 10’s (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Medirich Pharma Distribution Corp.Importer: Pharmakon Biotec Inc.
DRP-13687-18
Mar 28, 2028
Torlos-50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 50's and 100's)
RxVAT-exempt
TORRENT PHARMACEUTICALS LTD.India
TORRENT PHARMA PHILIPPINES, INC.
DRP-2845
Jul 24, 2027
UnbrandedLosartan Potassium
100 mg TabletOpaque White PVC/Aluminum Blister Pack x 10's (Box of 60's)
RxVAT-exempt
Pascual Laboratories, Inc.,Philippines
Watsons Personal Care Stores (Philippines), Inc.
DRP-5096-01
Dec 7, 2030
UnbrandedLosartan Potassium
100 mg TabletOpaque white PVC/Aluminum blister pack x 10's (Box of 60's)
RxVAT-exempt
Pascual Laboratories, Inc.,Philippines
Ritemed Phils., Inc.
DRP-5096-03
Feb 12, 2032
UnbrandedLosartan (as Potassium)
100mg TabletAlu/Red PVC Blister pack x 10's (Box of 100's)
RxVAT-exempt
Drugmaker's Laboratories IncPhilippines
TGP Pharma Inc.
DRP-7208-01
Oct 10, 2031
UnbrandedLosartan Potassium
50 mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Vamsler Phils. Incorporated
DR-XY45078
Feb 17, 2031
UnbrandedLosartan Potassium
50 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's Box of 100's; Alu/Clear PVC Blister Pack x 10's as Physician's Sample Box of 10's
RxVAT-exempt
Interphil Laboratories, Inc.Philippines
St. Joseph Drugstore
DRP-1456-05
Mar 19, 2029
UnbrandedLosartan (as Potassium)
50 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 30's)
RxVAT-exempt
XL Laboratories Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation
DRP-3183-06
Jun 7, 2037
UnbrandedLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s Box of 100's
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Diafarm Inc.Importer: Ambica International Corporation
DRP-5040-04
Jan 7, 2029
UnbrandedLosartan Potassium
50 mg Film-Coated TabletOpaque white PVC/Aluminum Blister Pack x 10's (Box of 60's)
RxVAT-exempt
Pascual Laboratories, Inc.,Philippines
South Star Drug
DRP-5095-04
Jan 23, 2032
VALLOSARLosartan Potassium
50 mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 10’s (Box of 30’s and 100’s)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., LtdChina
SwissPharmatech Co.Importer: AMB HK Enterprises Inc.
DRP-8522-03
Oct 25, 2029
VamzarLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Bulacan
Trader: Ultramed Pharma, Inc.
DR-XY45350
Apr 29, 2031
Vascure 50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Northmed Pharma and Medical Supplies DistributionImporter: Pharmakon Biotec Inc.
DRP-13687-17
Mar 28, 2028
VasotasLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
PSA Chemicals & Pharmaceuticals Pvt. Ltd.India
Suhitas Pharmaceuticals Inc.Importer: Orange Biotec Inc.
DRP-15448-05
Jul 10, 2029
VAZALIVELosartan Potassium
50 mg Film Coated TabletAlu/Alu blister pack x 10’s (Box of 30's and 100’s)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc.
DRP-13687-23
Mar 28, 2028
Vazortan 50Losartan Potassium
50 mg Film-coated TabletAlu/Alu blister pack x 10's (Box of 100's)
RxVAT-exempt
Medley Pharmaceuticals LimitedIndia
Ambica International Corporation
DRP-10664
Nov 3, 2031
VenosartanLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30's and 100's)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
JMED PharmaImporter: Pharmakon Biotec, Inc.
DRP-13687-21
Mar 28, 2028
VivasartanLosartan Potassium
100 mg Film-Coated TabletPVC/PVDC/Alu Blister Pack x 10's and 15's (Box of 30's)
RxVAT-exempt
Genveon Ilac Sanayi Ve Ticaret A.S.Turkey
Importer: Sandoz Philippines Corporation
DRP-2184
Jul 7, 2029
VivasartanLosartan Potassium
50 mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 10's and 15's Box of 30's
RxVAT-exempt
Sandoz Grup Saglik Urunleri Ilaclari Sanayi Ve Tiracet A.S. (Gebze 2)Turkey
Importer: Sandoz Philippines Corporation
DRP-2183
Jan 26, 2030
VonsartanLosartan Potassium
100 mg Film Coated TabletAlu/Red PVC Blister Pack x 10's and 20's (Box of 100's)
RxVAT-exempt
Vonwelt Inc.Philippines
—
DRP-13513
Feb 16, 2027
VonsartanLosartan Potassium
100 mg Film-Coated TabeltAlu/Red PVC Blister Pack x 10's and 20's (Box of 100's)
RxVAT-exempt
Vonwelt Inc.Philippines
—
DR-XY44163
Feb 16, 2027
WelsartanLosartan Potassium
50 mg Film-Coated TabletAlu/PVC/PVDC Blister Pack x 10's (Box of 30's and 100's)
RxVAT-exempt
Hebei Tiancheng Pharmaceutical Co., Ltd.China
Pharmacare Products CorporationImporter: AMB HK Enterprises Inc.
DRP-8522-07
Oct 25, 2029
WesartanLosartan Potassium
50 mg TabletAlu-White Opaque PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
LifeSquare Laboratories, Inc.Philippines
Westpoint Pharma Inc.
DRP-4706-03
Sep 22, 2031
WilopresLosartan Potassium
100 mg Film-Coated TabletAlu/White PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Willore Pharma Corporation
DRP-1667-01
Aug 11, 2030
WilopresLosartan Potassium
50 mg Film Coated TabletAlu/White PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Trader: Willore Pharma Corporation
DR-XY37022
Nov 26, 2029
YsartanLosartan Potassium
50 mg Film-Coated TabletAlu-Opaque White PVC Blister Pack x 10's (Box of 30's, 50's and 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Botika ni-Julia
DRP-12412-11
Jul 31, 2031
ZaranLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Gold Life Distribution Phils., Inc.
DR-XY37916
May 11, 2030
ZarnatLosartan Potassium
100 mg Film-Coated TabletAlu/PV Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Corbridge Group Phils., Inc.
DR-XY33208
Apr 16, 2031
ZarnatLosartan Potassium
50 mg Film-Coated TabletBlister Pack x 20's (Box of 100's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
Trader: Corbridge Group Phils., Inc.
DR-XY33519
Jun 22, 2027
ZarphilLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Synmedic LaboratoriesIndia
Phil Asia Pharma Inc.Importer: Ambica International Corporation
DRP-2591
Jul 31, 2028
ZarposeLosartan Potassium
500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Synmedic LaboratoriesIndia
Charmmed IncorporatedImporter: Ambica International Corporation
DRP-2591-01
Apr 26, 2028
Zartan-SLosartan Potassium
100 mg Film-Coated TabletAlu/White PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Sigma Medical Solution Trading Co., Inc.
DRP-1667-06
Aug 11, 2030
Zartan-SLosartan Potassium
50 mg Film-Coated TabletWhite PVDC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Hizon Laboratories, Inc.Philippines
Sigma Medical Solution Trading Co., Inc.
DRP-128-08
Oct 10, 2030
ZartapelLosartan Potassium
50 mg Film-Coated TabletAlu-Opaque White PVC Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Azarias Pharmaceutical Laboratories Inc.Philippines
Errapel Pharmed Corp.
DRP-12412-09
Aug 6, 2031
ZebesarLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister pack x 10's (Box of 100's)
RxVAT-exempt
Zim Laboratories LimitedIndia
Zebe TradingImporter: Medinova Pharmaceutical Inc.
DRP-8985-11
Aug 17, 2031
Zelosart-100Losartan Potassium
100 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's & 100’s)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Zeldix Pharma Inc.Importer: Pharmakon Biotec Inc.
DRP-13686-07
Mar 28, 2028
Zelosart-50Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's & 100’s)
RxVAT-exempt
Magbro Healthcare Pvt. Ltd.India
Zeldix Pharma Inc.Importer: Pharmakon Biotec Inc.
DRP-13687-08
Mar 28, 2028
ZilzartLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Synmedic LaboratoriesIndia
Quad-Gen PharmaceuticalsImporter: Ambica International Corporation
DRP-2591-06
Apr 26, 2028
Zilzart-SLosartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Stallion Laboratories Pvt. Ltd.India
Pharmasilv TradingImporter: Ambica International Corporation
DRP-5458-02
Aug 18, 2029
Zyltan 50Losartan Potassium
50mg Film-Coated TabletAlu/White Opaque PVC Blister Pack x 10's Box of 100's
RxVAT-exempt
Troikaa Pharmaceuticals Ltd.India
Troikaa Pharmaceuticals Philippines, Inc.
DR-XY41018
Jul 9, 2027
(no brand name)Losartan Potassium
100 mg Film-Coated TabletAlu/White PVC-PVDC Blister x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
—
DRP-11967
May 25, 2027
(no brand name)Losartan Potassium
100 mg Film-Coated TabletAlu/PVC/PVDC Blister x 10's (Box of 30's)
RxVAT-exempt
United International Pharma Co. Ltd.Vietnam
Ritemed Phils., Inc.
DRP-12006
May 27, 2027
(no brand name)Losartan potassium
50 mg Film-Coated TabletAlu/White PVC-PVDC Blister x 10's (Box of 30's)
RxVAT-exempt
Lloyd Laboratories, Inc.Philippines
—
DRP-11968
May 25, 2027
(no brand name)Losartan Potassium
50 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's & 100's)
RxVAT-exempt
Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Limited)India
Ambica International Corporation
DRP-12460
Aug 12, 2027
(no brand name)Losartan potassium
50 mg Film-coated TabletBlister Pack x 10's (Box of 100's)
RxVAT-exempt
Plethico Pharmaceuticals Ltd.India
Medethix, Inc.Importer: I.E. Medica, Inc.Trader: Wiscon Pharmaceuticals Pvt. Ltd.
DRP-996-04
Nov 12, 2027
(no brand name)Losartan Potassium
50 mg TabletAlu/Alu Blister Pack x 10's (Box of 100's)
RxVAT-exempt
Mankind Pharma Limited (Unit II)India
I.E. Medica Inc.
DRP-11012
Jan 3, 2027

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

United States (label)

Dosage forms and strengths (US label) US FDA label

3 DOSAGE FORMS AND STRENGTHS COZAAR, 25 mg, are white, oval, film-coated tablets with code 951 on one side. COZAAR, 50 mg, are white, oval, film-coated tablets with code 952 on one side and scored on the other. COZAAR, 100 mg, are white, teardrop-shaped, film-coated tablets with code 960 on one side. Tablets: 25 mg; 50 mg; and 100 mg. (3)

Warnings/Precautions

The boxed warning is shown at the top of this page.

Warnings and precautions (US label) US FDA label
  • Hypotension: Correct volume or salt depletion prior to administration of COZAAR. (5.2)
  • Monitor renal function and potassium in susceptible patients. (5.3, 5.4)
5.1 Fetal Toxicity

5.1 Fetal Toxicity COZAAR can cause fetal harm when administered to a pregnant woman. Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death. Resulting oligohydramnios can be associated with fetal lung hypoplasia and skeletal deformations.

Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death. When pregnancy is detected, discontinue COZAAR as soon as possible [see Use in Specific Populations (8.1)].

5.2 Hypotension in Volume- or Salt-Depleted Patients

5.2 Hypotension in Volume- or Salt-Depleted Patients In patients with an activated renin-angiotensin system, such as volume- or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may occur after initiation of treatment with COZAAR. Correct volume or salt depletion prior to administration of COZAAR [see Dosage and Administration (2.1)].

5.3 Renal Function Deterioration

5.3 Renal Function Deterioration Changes in renal function including acute renal failure can be caused by drugs that inhibit the renin-angiotensin system and by diuretics. Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, chronic kidney disease, severe congestive heart failure, or volume depletion) may be at particular risk of developing acute renal failure on COZAAR.

Monitor renal function periodically in these patients. Consider withholding or discontinuing therapy in patients who develop a clinically significant decrease in renal function on COZAAR [see Drug Interactions (7.3) and Use in Specific Populations (8.7)].

5.4 Hyperkalemia

5.4 Hyperkalemia Monitor serum potassium periodically and treat appropriately. Dosage reduction or discontinuation of COZAAR may be required [see Adverse Reactions (6.1)]. Concomitant use of other drugs that may increase serum potassium may lead to hyperkalemia [see Drug Interactions (7.1)].

Drug interactions

Drug or classSeverityEffectWhat to do
Potassium-raising drugs (potassium supplements, potassium-sparing diuretics, salt substitutes)Adjust or monitorHyperkalemia.Monitor serum potassium.
LithiumAdjust or monitorHigher lithium levels and toxicity.Monitor lithium levels.
NSAIDs, including COX-2 inhibitorsAdjust or monitorWorse kidney function, possible acute renal failure (older, volume-depleted or CKD patients); weaker antihypertensive effect.Monitor kidney function periodically.
Aliskiren (in diabetes)AvoidDual RAS blockade: hypotension, hyperkalemia, kidney function changes.Contraindicated in patients with diabetes.
ACE inhibitors, other ARBs, aliskiren (dual RAS blockade)AvoidMore hypotension, syncope, hyperkalemia and acute renal failure; no added benefit in VA NEPHRON-D.Avoid routine combination; monitor blood pressure, kidney function and electrolytes if used.

Severity scale (renalcarematters.com): Avoid: do not combine; Adjust or monitor: change the dose or monitor closely; Minor: usually no action.

renalcarematters.com, reviewed
Drug interactions (US label) US FDA label
  • Agents Increasing Serum Potassium: Risk of hyperkalemia. (7.1)
  • Lithium: Risk of lithium toxicity. (7.2)
  • NSAIDs: Increased risk of renal impairment and reduced diuretic, natriuretic, and antihypertensive effects. (7.3)
  • Dual Inhibition of the Renin-Angiotensin System: Increased risk of renal impairment, hypotension, syncope, and hyperkalemia. (7.4)
7.1 Agents Increasing Serum Potassium

7.1 Agents Increasing Serum Potassium Coadministration of losartan with other drugs that raise serum potassium levels may result in hyperkalemia. Monitor serum potassium in such patients.

7.2 Lithium

7.2 Lithium Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists. Monitor serum lithium levels during concomitant use.

7.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2…

7.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors) In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, coadministration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists (including losartan) may result in deterioration of renal function, including possible acute renal failure. These effects are usually reversible.

Monitor renal function periodically in patients receiving losartan and NSAID therapy. The antihypertensive effect of angiotensin II receptor antagonists, including losartan, may be attenuated by NSAIDs, including selective COX-2 inhibitors.

7.4 Dual Blockade of the Renin-Angiotensin System (RAS)

7.4 Dual Blockade of the Renin-Angiotensin System (RAS) Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, syncope, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. The Veterans Affairs Nephropathy in Diabetes (VA NEPHRON-D) trial enrolled 1448 patients with type 2 diabetes, elevated urinary-albumin-to-creatinine ratio, and decreased estimated glomerular filtration rate (GFR 30 to 89.9 mL/min), randomized them to lisinopril or placebo on a background of losartan therapy and followed them for a median of 2.2 years.

Patients receiving the combination of losartan and lisinopril did not obtain any additional benefit compared to monotherapy for the combined endpoint of decline in GFR, end stage renal disease, or death, but experienced an increased incidence of hyperkalemia and acute kidney injury compared with the monotherapy group. In most patients no benefit has been associated with using two RAS inhibitors concomitantly.

In general, avoid combined use of RAS inhibitors. Closely monitor blood pressure, renal function, and electrolytes in patients on COZAAR and other agents that affect the RAS. Do not coadminister aliskiren with COZAAR in patients with diabetes. Avoid use of aliskiren with COZAAR in patients with renal impairment (GFR <60 mL/min).

Drug Interactions No clinically significant drug interactions have been found in studies of losartan potassium with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital. However, rifampin has been shown to decrease the AUC of losartan and its active metabolite by 30% and 40%, respectively. Fluconazole, an inhibitor of cytochrome P450 2C9, decreased the AUC of the active metabolite by approximately 40%, but increased the AUC of losartan by approximately 70% following multiple doses.

Conversion of losartan to its active metabolite after intravenous administration is not affected by ketoconazole, an inhibitor of P450 3A4. The AUC of active metabolite following oral losartan was not affected by erythromycin, an inhibitor of P450 3A4, but the AUC of losartan was increased by 30%. The pharmacodynamic consequences of concomitant use of losartan and inhibitors of P450 2C9 have not been examined.

Subjects who do not metabolize losartan to active metabolite have been shown to have a specific, rare defect in cytochrome P450 2C9. These data suggest that the conversion of losartan to its active metabolite is mediated primarily by P450 2C9 and not P450 3A4.

Adverse reactions

Common

  • Upper respiratory infection (8% vs 7% placebo)
  • Dizziness (3% vs 2%)
  • Nasal congestion (2% vs 1%)
  • Back pain (2% vs 1%)

Serious

  • Fetal toxicity (boxed warning)
  • Hypotension in volume- or salt-depleted patients
  • Kidney function deterioration, including acute renal failure
  • Hyperkalemia
renalcarematters.com, reviewed
Adverse reactions (US label) US FDA label
  • Most common adverse reactions (incidence ≥2% and greater than placebo) are: dizziness, upper respiratory infection, nasal congestion, and back pain. (6.1)
  • To report SUSPECTED ADVERSE REACTIONS, contact Organon LLC, a subsidiary of Organon & Co., at 1-844-674-3200 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
6.1 Clinical Trials Experience

6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. Hypertension COZAAR has been evaluated for safety in more than 3300 adult patients treated for essential hypertension and 4058 patients/subjects overall.

Over 1200 patients were treated for over 6 months and more than 800 for over one year. Treatment with COZAAR was well-tolerated with an overall incidence of adverse events similar to that of placebo. In controlled clinical trials, discontinuation of therapy for adverse events occurred in 2.3% of patients treated with COZAAR and 3.7% of patients given placebo.

In 4 clinical trials involving over 1000 patients on various doses (10-150 mg) of losartan potassium and over 300 patients given placebo, the adverse events that occurred in ≥2% of patients treated with COZAAR and more commonly than placebo were: dizziness (3% vs. 2%), upper respiratory infection (8% vs. 7%), nasal congestion (2% vs. 1%), and back pain (2% vs. 1%). The following less common adverse reactions have been reported: Blood and lymphatic system disorders: Anemia.

Psychiatric disorders: Depression. Nervous system disorders: Somnolence, headache, sleep disorders, paresthesia, migraine. Ear and labyrinth disorders: Vertigo, tinnitus. Cardiac disorders: Palpitations, syncope, atrial fibrillation, CVA. Respiratory, thoracic and mediastinal disorders: Dyspnea. Gastrointestinal disorders: Abdominal pain, constipation, nausea, vomiting.

Skin and subcutaneous tissue disorders: Urticaria, pruritus, rash, photosensitivity. Musculoskeletal and connective tissue disorders: Myalgia, arthralgia. Reproductive system and breast disorders: Impotence. General disorders and administration site conditions: Edema. Cough Persistent dry cough (with an incidence of a few percent) has been associated with ACE-inhibitor use and in practice can be a cause of discontinuation of ACE-inhibitor therapy.

Two prospective, parallel-group, double-blind, randomized, controlled trials were conducted to assess the effects of losartan on the incidence of cough in hypertensive patients who had experienced cough while receiving ACE-inhibitor therapy. Patients who had typical ACE-inhibitor cough when challenged with lisinopril, whose cough disappeared on placebo, were randomized to losartan 50 mg, lisinopril 20 mg, or either placebo (one study, n=97) or 25 mg hydrochlorothiazide (n=135).

The double-blind treatment period lasted up to 8 weeks. The incidence of cough is shown in Table 1 below. Table 1 Study 1 Demographics = (89% Caucasian, 64% female) HCTZ Losartan Lisinopril Cough 25% 17% 69% Study 2 Demographics = (90% Caucasian, 51% female) Placebo Losartan Lisinopril Cough 35% 29% 62% These studies demonstrate that the incidence of cough associated with losartan therapy, in a population that all had cough associated with ACE-inhibitor therapy, is similar to that associated with hydrochlorothiazide or placebo therapy.

Cases of cough, including positive re-challenges, have been reported with the use of losartan in postmarketing experience. Hypertensive Patients with Left Ventricular Hypertrophy In the Losartan Intervention for Endpoint (LIFE) study, adverse reactions with COZAAR were similar to those reported previously for patients with hypertension.

Nephropathy in Type 2 Diabetic Patients In the Reduction of Endpoints in NIDDM with the Angiotensin II Receptor Antagonist Losartan (RENAAL) study involving 1513 patients treated with COZAAR or placebo, the overall incidences of reported adverse events were similar for the two groups. Discontinuations of COZAAR because of side effects were similar to placebo (19% for COZAAR, 24% for placebo).

The adverse events, regardless of drug relationship, reported with an incidence of ≥4% of patients treated with COZAAR and occurring with ≥2% difference in the losartan group vs. placebo on a background of conventional antihypertensive therapy, were asthenia/fatigue, chest pain, hypotension, orthostatic hypotension, diarrhea, anemia, hyperkalemia, hypoglycemia, back pain, muscular weakness, and urinary tract infection.

6.2 Postmarketing Experience

6.2 Postmarketing Experience The following additional adverse reactions have been reported in postmarketing experience with COZAAR. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to estimate their frequency reliably or to establish a causal relationship to drug exposure: Digestive: Hepatitis.

General Disorders and Administration Site Conditions: Malaise. Hematologic: Thrombocytopenia. Hypersensitivity: Angioedema, including swelling of the larynx and glottis, causing airway obstruction and/or swelling of the face, lips, pharynx, tongue, and/or swelling of the intestine has been reported; some of these patients previously experienced angioedema with other drugs including ACE inhibitors.

Vasculitis, including Henoch-Schönlein purpura, has been reported. Anaphylactic reactions have been reported. Metabolic and Nutrition: Hyponatremia. Musculoskeletal: Rhabdomyolysis. Nervous System Disorders: Dysgeusia. Skin: Erythroderma.

Adverse reaction frequency tables (US label) US FDA label
Table 1
Study 1Demographics = (89% Caucasian, 64% female)HCTZLosartanLisinopril
Cough25%17%69%
Study 2Demographics = (90% Caucasian, 51% female)PlaceboLosartanLisinopril
Cough35%29%62%

Monitoring parameters

  • Serum creatinine and potassium 2 to 4 weeks after starting or changing the dose; a creatinine rise up to 30% is expected and is not a reason to stop. Correct volume depletion before starting (label). KDIGO 2024 supports continuing the ARB when eGFR falls below 30. Kidney
  • Serum potassium periodically
  • Kidney function periodically, especially with renal artery stenosis, CKD, severe heart failure or volume depletion
  • Blood pressure
  • Stop at once if pregnancy is detected
renalcarematters.com, reviewed

Pregnancy considerations

Pregnancy (US label) US FDA label

8.1 Pregnancy Risk Summary COZAAR can cause fetal harm when administered to a pregnant woman. Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death. Most epidemiologic studies examining fetal abnormalities after exposure to antihypertensive use in the first trimester have not distinguished drugs affecting the renin-angiotensin system from other antihypertensive agents.

When pregnancy is detected, discontinue COZAAR as soon as possible (see Clinical Considerations). The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. All pregnancies have a background risk of birth defect, loss, or other adverse outcomes. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively.

Clinical Considerations Disease-associated Maternal and/or Embryo/Fetal Risk Hypertension in pregnancy increases the maternal risk for pre-eclampsia, gestational diabetes, premature delivery, and delivery complications (e.g., need for cesarean section, post-partum hemorrhage). Hypertension increases the fetal risk for intrauterine growth restriction and intrauterine death.

Pregnant women with hypertension should be carefully monitored and managed accordingly. Fetal/Neonatal Adverse Reactions Oligohydramnios in pregnant women who use drugs affecting the renin-angiotensin system in the second and third trimesters of pregnancy can result in the following: reduced fetal renal function leading to anuria and renal failure, fetal lung hypoplasia, skeletal deformations, including skull hypoplasia, hypotension, and death.

In the unusual case that there is no appropriate alternative to therapy with drugs affecting the renin-angiotensin system for a particular patient, apprise the mother of the potential risk to the fetus. In patients taking COZAAR during pregnancy, perform serial ultrasound examinations to assess the intra-amniotic environment.

Fetal testing may be appropriate, based on the week of gestation. If oligohydramnios is observed, discontinue COZAAR, unless it is considered lifesaving for the mother. Patients and physicians should be aware, however, that oligohydramnios may not appear until after the fetus has sustained irreversible injury. Closely observe neonates with histories of in utero exposure to COZAAR for hypotension, oliguria, and hyperkalemia.

In neonates with a history of in utero exposure to COZAAR, if oliguria or hypotension occurs, support blood pressure and renal perfusion. Exchange transfusions or dialysis may be required as a means of reversing hypotension and replacing renal function. Data Animal Data Losartan potassium was administered orally to rats during the period of late gestation through lactation (Gestation Day 15 through Lactation Day 20) at doses of 10, 25, and 100 mg/kg/day.

Losartan potassium has been shown to produce adverse effects in rat fetuses and neonates, including decreased body weight, delayed physical and behavioral development, mortality and renal toxicity. With the exception of neonatal weight gain (which was affected at doses as low as 10 mg/kg/day), doses associated with these effects exceeded 25 mg/kg/day (approximately three times the maximum recommended human dose of 100 mg on a mg/m 2 basis).

These findings are attributed to drug exposure in late gestation and during lactation. Significant levels of losartan and its active metabolite were shown to be present in rat fetal plasma during late gestation and in rat milk.

Mechanism of action

12.1 Mechanism of Action Angiotensin II [formed from angiotensin I in a reaction catalyzed by angiotensin converting enzyme (ACE, kininase II)] is a potent vasoconstrictor, the primary vasoactive hormone of the renin-angiotensin system, and an important component in the pathophysiology of hypertension. It also stimulates aldosterone secretion by the adrenal cortex.

Losartan and its principal active metabolite block the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT 1 receptor found in many tissues, (e.g., vascular smooth muscle, adrenal gland). There is also an AT 2 receptor found in many tissues but it is not known to be associated with cardiovascular homeostasis.

Neither losartan nor its principal active metabolite exhibits any partial agonist activity at the AT 1 receptor, and both have much greater affinity (about 1000-fold) for the AT 1 receptor than for the AT 2 receptor. In vitro binding studies indicate that losartan is a reversible, competitive inhibitor of the AT 1 receptor.

The active metabolite is 10 to 40 times more potent by weight than losartan and appears to be a reversible, non-competitive inhibitor of the AT 1 receptor. Neither losartan nor its active metabolite inhibits ACE (kininase II, the enzyme that converts angiotensin I to angiotensin II and degrades bradykinin), nor do they bind to or block other hormone receptors or ion channels known to be important in cardiovascular regulation.

US FDA label

Pharmacodynamics

Pharmacodynamics (US label) US FDA label

12.2 Pharmacodynamics Losartan inhibits the pressor effect of angiotensin II (as well as angiotensin I) infusions. A dose of 100 mg inhibits the pressor effect by about 85% at peak with 25-40% inhibition persisting for 24 hours. Removal of the negative feedback of angiotensin II causes a doubling to tripling in plasma renin activity and consequent rise in angiotensin II plasma concentration in hypertensive patients.

Losartan does not affect the response to bradykinin, whereas ACE inhibitors increase the response to bradykinin. Aldosterone plasma concentrations fall following losartan administration. In spite of the effect of losartan on aldosterone secretion, very little effect on serum potassium was observed. The effect of losartan is substantially present within one week but in some studies the maximal effect occurred in 3-6 weeks.

In long-term follow-up studies (without placebo control) the effect of losartan appeared to be maintained for up to a year. There is no apparent rebound effect after abrupt withdrawal of losartan. There was essentially no change in average heart rate in losartan-treated patients in controlled trials.

Pharmacokinetics

Key PK parameters

BioavailabilityAbout 33% (first-pass)
Time to peakLosartan 1 hour; active metabolite 3 to 4 hours
Half-lifeLosartan about 2 hours; active metabolite 6 to 9 hours
Half-life in kidney failure (ESKD) kidneyNot reported; AUC 50% to 90% higher at CrCl 30 to 74 mL/min (label)
Volume of distributionLosartan about 34 L; metabolite about 12 L
Protein bindingHighly bound (free fraction 1.3% losartan, 0.2% metabolite)
Metabolism (CYP, transporters)CYP2C9 and CYP3A4; about 14% converted to the active carboxylic acid metabolite
Active metabolitesCarboxylic acid metabolite (E-3174)
Renal excretion kidneyAbout 4% unchanged and 6% as active metabolite in urine (oral); about 35% of radiolabel in urine, 60% in feces
Dialyzability kidneyNo: neither losartan nor its active metabolite is removed by hemodialysis (label).
renalcarematters.com, reviewed
Half-life and elimination (verbatim, US label)

Elimination: Total plasma clearance of losartan and the active metabolite is about 600 mL/min and 50 mL/min, respectively, with renal clearance of about 75 mL/min and 25 mL/min, respectively.

The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.

After single doses of losartan administered orally, about 4% of the dose is excreted unchanged in the urine and about 6% is excreted in urine as active metabolite.

Biliary excretion contributes to the elimination of losartan and its metabolites.

In this study, renal clearance was reduced by 55-85% for both losartan and its active metabolite in patients with mild or moderate renal insufficiency.

Pharmacokinetics (US label) US FDA label

12.3 Pharmacokinetics Absorption: Following oral administration, losartan is well absorbed and undergoes substantial first-pass metabolism. The systemic bioavailability of losartan is approximately 33%. Mean peak concentrations of losartan and its active metabolite are reached in 1 hour and in 3-4 hours, respectively. While maximum plasma concentrations of losartan and its active metabolite are approximately equal, the AUC (area under the curve) of the metabolite is about 4 times as great as that of losartan.

A meal slows absorption of losartan and decreases its C max but has only minor effects on losartan AUC or on the AUC of the metabolite (~10% decrease). The pharmacokinetics of losartan and its active metabolite are linear with oral losartan doses up to 200 mg and do not change over time. Distribution: The volume of distribution of losartan and the active metabolite is about 34 liters and 12 liters, respectively.

Both losartan and its active metabolite are highly bound to plasma proteins, primarily albumin, with plasma free fractions of 1.3% and 0.2%, respectively. Plasma protein binding is constant over the concentration range achieved with recommended doses. Studies in rats indicate that losartan crosses the blood-brain barrier poorly, if at all.

Metabolism: Losartan is an orally active agent that undergoes substantial first-pass metabolism by cytochrome P450 enzymes. It is converted, in part, to an active carboxylic acid metabolite that is responsible for most of the angiotensin II receptor antagonism that follows losartan treatment. About 14% of an orally-administered dose of losartan is converted to the active metabolite.

In addition to the active carboxylic acid metabolite, several inactive metabolites are formed. In vitro studies indicate that cytochrome P450 2C9 and 3A4 are involved in the biotransformation of losartan to its metabolites. Elimination: Total plasma clearance of losartan and the active metabolite is about 600 mL/min and 50 mL/min, respectively, with renal clearance of about 75 mL/min and 25 mL/min, respectively.

The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours. After single doses of losartan administered orally, about 4% of the dose is excreted unchanged in the urine and about 6% is excreted in urine as active metabolite. Biliary excretion contributes to the elimination of losartan and its metabolites.

Following oral 14 C-labeled losartan, about 35% of radioactivity is recovered in the urine and about 60% in the feces. Following an intravenous dose of 14 C-labeled losartan, about 45% of radioactivity is recovered in the urine and 50% in the feces. Neither losartan nor its metabolite accumulates in plasma upon repeated once-daily dosing.

Specific Populations Pediatric: Pharmacokinetic parameters after multiple doses of losartan (average dose 0.7 mg/kg, range 0.36 to 0.97 mg/kg) as a tablet to 25 hypertensive patients aged 6 to 16 years are shown in Table 4 below. Pharmacokinetics of losartan and its active metabolite were generally similar across the studied age groups and similar to historical pharmacokinetic data in adults.

The principal pharmacokinetic parameters in adults and children are shown in the table below. Table 2: Pharmacokinetic Parameters in Hypertensive Adults and Children Age 6-16 Following Multiple Dosing Adults given 50 mg once daily for 7 days N=12 Age 6-16 given 0.7 mg/kg once daily for 7 days N=25 Parent Active Metabolite Parent Active Metabolite AUC 0-24 (ng∙hr/mL) Mean ± standard deviation 442 ± 173 1685 ± 452 368 ± 169 1866 ± 1076 C MAX (ng/mL) 224 ± 82 212 ± 73 141 ± 88 222 ± 127 T 1/2 (h) Harmonic mean and standard deviation 2.1 ± 0.70 7.4 ± 2.4 2.3 ± 0.8 5.6 ± 1.2 T PEAK (h) Median 0.9 3.5 2.0 4.1 CL REN (mL/min) 56 ± 23 20 ± 3 53 ± 33 17 ± 8 The bioavailability of the suspension formulation was compared with losartan tablets in healthy adults.

The suspension and tablet are similar in their bioavailability with respect to both losartan and the active metabolite [see Dosage and Administration (2.5)]. Geriatric and Gender: Losartan pharmacokinetics have been investigated in the elderly (65-75 years) and in both genders. Plasma concentrations of losartan and its active metabolite are similar in elderly and young hypertensives.

Plasma concentrations of losartan were about twice as high in female hypertensives as male hypertensives, but concentrations of the active metabolite were similar in males and females. No dosage adjustment is necessary [see Dosage and Administration (2.1)]. Race: Pharmacokinetic differences due to race have not been studied [see Use in Specific Populations (8.6)].

Renal Insufficiency: Following oral administration, plasma concentrations and AUCs of losartan and its active metabolite are increased by 50-90% in patients with mild (creatinine clearance of 50 to 74 mL/min) or moderate (creatinine clearance 30 to 49 mL/min) renal insufficiency. In this study, renal clearance was reduced by 55-85% for both losartan and its active metabolite in patients with mild or moderate renal insufficiency.

Neither losartan nor its active metabolite can be removed by hemodialysis [see Warnings and Precautions (5.3) and Use in Specific Populations (8.7)]. Hepatic Insufficiency: Following oral administration in patients with mild to moderate alcoholic cirrhosis of the liver, plasma concentrations of losartan and its active metabolite were, respectively, 5-times and about 1.7-times those in young male volunteers.

Compared to normal subjects the total plasma clearance of losartan in patients with hepatic insufficiency was about 50% lower and the oral bioavailability was about doubled. Use a starting dose of 25 mg for patients with mild to moderate hepatic impairment. COZAAR has not been studied in patients with severe hepatic impairment [see Dosage and Administration (2.4) and Use in Specific Populations (8.8)].

Drug Interactions No clinically significant drug interactions have been found in studies of losartan potassium with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital. However, rifampin has been shown to decrease the AUC of losartan and its active metabolite by 30% and 40%, respectively. Fluconazole, an inhibitor of cytochrome P450 2C9, decreased the AUC of the active metabolite by approximately 40%, but increased the AUC of losartan by approximately 70% following multiple doses.

Conversion of losartan to its active metabolite after intravenous administration is not affected by ketoconazole, an inhibitor of P450 3A4. The AUC of active metabolite following oral losartan was not affected by erythromycin, an inhibitor of P450 3A4, but the AUC of losartan was increased by 30%. The pharmacodynamic consequences of concomitant use of losartan and inhibitors of P450 2C9 have not been examined.

Subjects who do not metabolize losartan to active metabolite have been shown to have a specific, rare defect in cytochrome P450 2C9. These data suggest that the conversion of losartan to its active metabolite is mediated primarily by P450 2C9 and not P450 3A4.

Formulary and pricing (Philippines)

Government price references

PreparationPrice (PHP)UnitType
Losartan 50 mg Tablet₱0.70–₱7.00Reference ₱0.80per tabletDPRI procurement range
Losartan 100 mg Tablet₱1.70–₱8.00Reference ₱2.50per tabletDPRI procurement range
50 mg (as potassium) tablet₱9.00per tabletPhilHealth GAMOT fixed fee
100 mg (as potassium) tablet₱12.00per tabletPhilHealth GAMOT fixed fee

PhilHealth GAMOT fixed fee paid to the accredited GAMOT pharmacy per unit dispensed Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)

These are government procurement and reimbursement references, not retail prices. Sources:

Formulary and coverage

Philippine National FormularyListed as Losartan (as potassium salt)
PNF listingOral: 50 mg and 100 mg tablet
PhilHealth GAMOTYes (listed since July 28, 2025)
PhilHealth YAKAP (formerly Konsulta)Yes

Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. COZAAR · Organon LLC [US FDA-approved label, version 9, January 20, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9949448f-c3b9-44ee-94ed-c1aca8c90f39
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  3. PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
  4. PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
  5. PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
  6. DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
  7. Organon LLC. (2026). COZAAR (losartan potassium) [Prescribing information; US FDA-approved label, NDA020386, set ID 9949448f-c3b9-44ee-94ed-c1aca8c90f39, version effective January 20, 2026]. DailyMed, U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9949448f-c3b9-44ee-94ed-c1aca8c90f39
  8. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2024). KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International, 105(4S), S117–S314. https://doi.org/10.1016/j.kint.2023.10.018
  9. Schwartz, G. J., Muñoz, A., Schneider, M. F., Mak, R. H., Kaskel, F., Warady, B. A., & Furth, S. L. (2009). New equations to estimate GFR in children with CKD. Journal of the American Society of Nephrology, 20(3), 629–637. https://doi.org/10.1681/ASN.2008030287

renalcarematters.com content: Kidney and pediatric dosing: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 16, 2026. Dosing, interaction, adverse-effect and monitoring summary: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 16, 2026.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .